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Abstract: 
The Insulin/IGF Signaling Regulator Cytohesin/GRP-1 
Modulates Sensitivity to Excitotoxicity in C. elegans 
By 
Nazila Tehrani 
 
Advisor: Dr. Itzhak Mano 
 
Excitotoxicity is a form of neurodegeneration that serves as the main underlying cause of 
brain damage in stroke/brain ischemia, and a contributing factor in a range of neurological 
diseases such as Epilepsy, ALS, Alzheimer, and Huntington’s disease. In excitotoxicity, over-
activation of glutamate receptors causes necrotic neuronal cell death. In spite of intense study of 
excitotoxicity, the molecular mechanisms that lead from glutamate receptor activation to necrotic 
death remain a mystery. Aging neurons are known to be more vulnerable to excitotoxicity and 
less likely to recover, but the underlying reasons for the increased cellular vulnerability are 
unknown. To gain insight into the core process of excitotoxicity and factors that affect neuronal 
vulnerability, we turn to a model system that offers simplified but conserved signaling cascades 
and strong research tools. We therefore study excitotoxicity in the nematode C. elegans, in which 
a strong track record of studies of cell death mechanisms and signaling cascades suggests that 
this genetically accessible model system can help illuminate critical and conserved cellular 
processes.  Our model combines a deletion of glutamate transporter 3 (glt-3) in a sensitized 
background (nuIs5), resulting in glutamate-triggered necrotic cell death. Previously, other 
iv 
 
investigators showed the role of the evolutionary conserved Insulin/IGF Signaling pathway (IIS) 
in longevity and cell stress resistance. Recently, we were able to show that the IIS cascade also 
controls vulnerability of postsynaptic neurons to excitotoxicity, by regulating the 
nuclear/cytoplasmic localization of the neuroprotective transcription factor FOXO3/DAF-16. 
Active IIS signaling causes FOXO/DAF-16 to be sequestered in the cytoplasm, while IIS 
inhibition allows FOXO/DAF-16 to enter the nucleus and activate protective genes. To gain 
further insight into the ability of this signaling cascade to regulate neurodegeneration, we study 
factors that are upstream and downstream of the IIS cascade and may be involved in 
excitotoxicity. As a preliminary step, I confirmed the involvement of IIS pathway in 
excitotoxicity. I worked towards preparing an excitotoxicity strain that is permissible for RNAi 
effect in neurons, to facilitate the ability to screen for the effect of FOXO/DAF-16 candidate 
target genes on neuroprotection. I then examined potential upstream modulators of IIS, and 
focused on the relationship between the Cytohesin/GRP-1 protein complex (previously shown to 
control insulin-regulated metabolism in mammals) and IIS in excitotoxicity.  I observed that 
mutations that are expected to decrease the complex’s activity and its potentiation of IIS 
signaling reduced susceptibility to excitotoxicity, while an over-activation of this complex 
increased neuronal vulnerability. These results support that the Cytohesin/GRP-1 complex 
regulates the ability of the IIS cascade to modulate excitotoxicity. As a preliminary step to 
examine a possible direct communication between glutamate receptors and Cytohesin/GRP-1 IIS 
complexes, I examined their cellular localization. I observed a rough co-localization of the 
Cytohesin/GRP-1 complex components PPK-1 and GRP-1 and the glutamate receptor subunit 
GLR-1. Put together, these observations suggest that the Cytohesin/GRP-1 complex modulates 
IIS cascade’s ability to regulate the susceptibility to excitotoxic neurodegeneration, and that 
v 
 
glutamate might directly regulate this signaling cascade. We therefore provide novel insights into 
conserved signaling cascades that control neuronal sensitivity in nematode excitotoxicity. We 
hope that these new insights could inspire new research directions in the search for therapeutic 
interventions in stroke and brain ischemia. 
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Introduction: 
 
a) Excitotoxicity, a condition that involves over-stimulation by 
Glutamate, is a central process in neurodegenerative brain pathologies: 
 
Excitotoxicity is one of the main causes of lasting neuronal damage and 
neurodegenerative disease 
1–4
. Excitotoxicity is the result of excessive neurotransmitter signaling, 
in which the exposure of receptors to the excitatory amino acid Glutamate for prolonged time 
causes neuronal cell injury or necrotic cell death.  Such a neurological cell death is the main 
cause of cell damage in stroke/brain ischemia, and a common down-spiral pathway for cell death 
in several diseases such as epilepsy, Huntington, ALS, and Alzheimer 
5
.  Glutamate (Glu) is the 
major excitatory neurotransmitter in the brain 
6
. Under normal conditions, after Glu is released 
from the presynaptic cell, it binds to Glu receptors (GluRs) on the postsynaptic neurons and 
allows Na
+
 and Ca
2+ 
to enter the cell, thus depolarizing the postsynaptic cell and activating 
several different pathways. To terminate the signaling pulse and clear the synapse in preparation 
for the next neuronal impulse, the released Glu is then taken up by Glu transporters (GluTs), 
which are located on the neurons and glia cells that surround the synapse 
7
. However, under 
pathological conditions, Glu clearance slows down and eventually fails 
4,8–10
 . When there is a 
lack of energy in the brain (as happens during brain ischemia), Glu is not taken up, but rather 
accumulates in the synapse, and this causes over-excitation of the postsynaptic cell. The influx of 
ions causes exaggerated depolarization that, together with the excessive Ca
2+
 influx, causes 
swelling and lysis of the cell, leading to necrotic cell death. Since Glu is a common metabolite 
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present in high concentration in the cytoplasm of all cells, these lysed cells release more Glu and 
calcium, which causes excitation of neighboring cells and even more cell death 
1,4,5,7,8
. 
A. 
 
B. 
 
Figure 1 Glutamate signaling. 
Figure 1: Glutamate signaling. A) Normal glutamate signaling: Glu is released from the pre-
synaptic cell into the synaptic cleft and binds to and activates glutamate receptor/channels. These 
receptor/channels open and Ca
2+
 and Na
+ 
ions enter the postsynaptic cell. The released Glu is 
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simultaneously picked up by glutamate transporters (GluTs) located on the glia cells to terminate 
signaling. B) Excitotoxicity condition: There is an excess amount of glutamate in the synapse 
caused by GluT malfunction; therefore, the glutamate receptors are over-activated, excessive 
amount of Ca
2+
 enters the cells, eventually leading to necrotic cell death. 
b) Glutamate is the major excitatory neurotransmitter in the central 
nervous system 
Glutamate is the most important excitatory neurotransmitter in the central nervous 
system. Glutamate is involved in learning and memory and also plays role in central nervous 
system development
7
. There are two ways to generate glutamate in central nervous system: de 
novo synthesis or recycling. While all cells can synthesize Glu de novo by basic metabolic 
pathways, neuronally released Glu can be recycled in what is called the glutamate-glutamine 
cycle: after release of glutamate to extracellular space, glutamate is taken up by the astrocyte. 
The astrocyte enzyme, glutamine synthase (GS) uses ATP to convert glutamate to glutamine. 
The astrocyte then releases the glutamine to extracellular space. Glutamine is consequently 
uptaken by the presynaptic neuron, which then uses the enzyme phosphate activated glutaminase 
(PAG) to convert glutamine to glutamate. Glutamate from either de novo synthesis or recycling 
is then pumped into glutamate-containing synaptic vesicles near the synaptic cleft, where it will 
be later release (Figure 2). 
4 
 
 
Figure 2 Glutamate-Glutamine cycle. 
Figure 2: Glutamate-Glutamine cycle. Glutamate is taken up by glutamate transporters into 
glial cells, where GS converts glutamate to glutamine. Then the glutamine is released into 
extracellular area and is taken by the presynaptic neurons, where it is converted back to 
glutamate by using ATP and PAG enzyme. 
     Glutamate mediates its effect by activating glutamate-gated cation channels called ionotropic 
glutamate receptors (iGluRs), and glutamate-activated G-protein coupled receptors called 
metabotropic glutamate receptors (mGluRs). Some mGluRs inhibit cAMP signaling, while 
others activate Phospholipase C (PLC) and cause production of inositol-1,4,5-tri-sphosphate 
(IP3) and  diacylglycerol (DAG) from L-3-phosphatidylmyo-inositol-4,5-bisphosphate (PIP2). 
DAG is then able to activate PKC and IP3 becomes an agonist for IP3 receptors, which leads to 
the release of Ca
2+
 from the endoplasmic reticulum 
7,11
.  iGluRs (many times labeled just GluRs) 
are subdivided to three different groups according to their physiological properties and the 
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xenobiotic glutamate-like agonist that serves as their specific agonist: kainate, α-amino-3-
hydroxy-5-methyl-4-isoxazole propionic acid (AMPA), and N-methyl-D-aspartate (NMDA). 
iGluRs are hetero-tetrameric complexes of similar subunits, and the identity of the subunits 
determines the specific properties of the complex. AMPA-Rs and NMDA-Rs are two main 
receptors that are involved in normal physiology and excitotoxicity. The different GluRs are 
usually co-localized in the postsynaptic membrane by their binding to scaffolding proteins that 
form the Post Synaptic Density, such as PSD95 (a protein that contains a protein-protein 
interaction domain called the PDZ domain). Most AMPA-Rs have high permeability for Na
+ 
and 
K
+
 and low permeability for Ca
2+
; however, there are some AMPA receptors (because of the 
specific subunits that make up the tetrameric complex) are permeable to Ca
2+
.  AMPA receptors 
open very fast, but they also desensitize very fast. On the other hand, NMDA receptors are 
permeable to Ca
2+
; but in resting polarized membrane potential, these receptors are blocked by a 
magnesium ion (Mg
2+
), which is expelled from the channel following sufficient depolarization. 
Thus, while weak depolarization activates only AMPA-Rs, strong depolarization due to robust 
AMPA-R activation causes the removal of Mg
2+
 from NMDA receptor so Ca
2+
 can enter the cell 
and activate several different pathways 
11
. NMDA-Rs therefore have a special physiological role 
as detectors of concerted or enhanced stimulation. Moreover, under pathological conditions of 
even more intense Glu signaling, the NMDA receptor plays a role in both cell death and cell 
survival. A large body of evidence suggests that the localization of NMDA receptors determine 
their functions. NMDA receptors can be localized at synapses or on the dendritic shaft, a location 
referred to as extra-synaptic. When there is low level of excitation, Glu binds to NMDA 
receptors inside the synapse, open these receptor/channels, and lets the Ca
2+
/Na
+
 enter the cell; 
the Glu is taken up by GluTs before affecting surrounding cells.  However, when there is over-
6 
 
excitation, Glu spills out of the synapse and the extra-synaptic NMDA receptors also become 
activated 
5,12
. While the view that assigns a special role for specific subunit combination in 
extrasynaptic NMDA-Rs is prominent in the field, others have challenged this view 
13
 . 
 
 
 
Figure 3 Release of glutamate to bind to glutamate receptors 
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Figure 3: Release of glutamate to bind to glutamate receptors. A) Under normal conditions, 
small amounts of glutamate are release and they bind to the synaptic AMPA and NMDA 
receptors. Activation of these receptors cause physiological signaling and supports the neuronal 
survival. B) Excess release of glutamate causes the activation of extrasynaptic NMDA in 
addition to synaptic receptors. The combined over- activation of synaptic and extrasynaptic 
receptors causes the neuronal death 
8
. 
c) Glutamate is removed from the synapse by specialized transporters: 
  Under normal resting conditions the concentration of extracellular Glu in the synapses is 
25 nM 
14
;  however, during excitation the concentration of synaptic glutamate increases to 10 
mM. Since the excess amount of glutamate is very dangerous for the cell, it is quickly cleared 
from synapses by glutamate transporters. There are five kinds of glutamate transporters (GluTs, 
in mammals called EAAT1-5) 
7,9.  EAAT1-2 are located in the astrocytes, EAAT-3 and EAAT4 
are  located in postsynaptic cells, and the EAAT5 is mostly located in retina
7. The crystal 
structure of GluTs showed that GluTs are organized as homotrimers. Each subunit functions 
independently and its structure contains eight transmembrane domains and two hairpins, one 
located between TM 6 and 7  and the other between TM 7 and 8, an area that makes up the 
catalytic core of the transporter 
9
. 
 
Figure 4 Glutamate transporter structure 
8 
 
. 
Figure 4. Glutamate transporter structure. GluTs contain eight TM and two hairpins domains 
(this figure is adopted from 
9
). 
 
Although a full cycle of the transport reaction is slow relative to the speed of signaling, 
Glu binds to the GluTs at the same rate as it binds to NMDA receptors and AMPA receptors. 
The expression of high density of GluTs at the synapses helps ensure that in spite of the slow 
turnover rate of the transporter, all of the extra Glu in the extracellular space is space collected 
(first by mere binding to the transporters, and slightly later by actual transport)
14
.  There are two 
different conformations observed in the GluTs: outward- and inward- facing conformation. Glu, 
accompanied by Na
+
 ions, binds to the outward-facing conformation. Now the transporter can 
change the conformation to the inward-facing conformation and release the Glu and Na
+
 ions to 
the cytoplasm. Then K
+
 in the cytoplasm binds to the inward-facing conformation, allowing the 
transporter to change the conformation back to the outward-facing conformation
14
. Glu is found 
in high concentrations (~10 mM) in the cytoplasm of all cells, including the glia cells and 
neurons in charge of Glu clearance. Therefore, bringing synaptic concentrations of Glu back to 
25 nM requires Glu transport into the cell against its concentration gradient. The driving force 
for Glu uptake is based on the electrochemical gradient of Na
+
, H
+
, and K
+
. Together with the 
incoming glutamate, there is co-transport of 3 Na
+
 and H
+
 ions from the extra-cellular side and a 
counter-transport of K
+
 from inside the cell, along their own concentration gradients. The 
translocation of these ions down their sharp concentration gradients provides enough driving 
force that enables the GluT to move Glu against its own concentration gradient
7
. However, when 
there is a problem with the electrochemical gradients of Na
+
 and K
+
, this causes the sharp decline 
in Glu removal from the synapse (Glu can even come out of the glial cell instead of going 
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inside
10
, so the transport is reversed). Since Glu transport is so dependent on the electrochemical 
gradients, it becomes extremely sensitive to any change, and will be the first system to shut down 
during a gradual decline in cellular energy levels. For example, in ischemic stroke, when there is 
energy failure, malfunction in Na
+
/ K
+
 pumps is induced. Though all cells in the body are 
affected by energy shortage and the disruption of ion gradients, brain cells are particularly 
sensitive because of the combined effect on GluTs and GluRs. The diminished electrochemical 
gradient very quickly leads to the malfunction of the glutamate transporters. Glu then has a 
catalytic effect on the neurons that express GluRs, causing widespread permeabilization to Na
+
 
and Ca
2+
.  In this case, accumulation of Na
+
 (coming through both AMPA and NMDA receptors) 
inside the cells causes the more water to enter the cell and, at the end, causes cell burst. In 
addition, the excessive activation of NMDA glutamate receptors and a toxic influx of Ca
2+
 into 
the postsynaptic cells, over-activates many Ca
2+
-dependent enzymes and cascades, eventually 
causing necrotic cell death in these cells 
1,4–6,8
. The molecular/biochemical nature of these 
cascades and the relative contribution of different suggested mechanisms to the core process of 
excitotoxicity is a matter of much debate. 
d) Energy plays a significant role in the glutamate metabolism 
 
   As mentioned before, GluTs use an electrochemical gradient to clear the excess amount 
of Glu from synapses. The electrochemical gradient is maintained by Na
+
/K
+ 
pumps 
7
. There are 
two ways that pumps get their energy: oxidative phosphorylation (mitochondria uses the oxygen 
to produce ATP) 
15
 and glycolysis (using glucose to produce ATP) 
16,17
.  Therefore, blockage of 
generation of energy from each of these processes would cause the malfunction of Na
+
/K
+.
 
pumps and thus, cause the malfunction of GluTs 
18,19
 (Figure 5). For example, ischemic stroke 
10 
 
happens as a result of blockage of arteries which causes deprivation of both glucose and oxygen 
and at the end excitotoxicity and cell death 
20
. 
 
A. 
 
 
B. 
 
Figure 5 Involvement of energy in the excitotoxicity 
Figure 5: Involvement of energy in the excitotoxicity.  A) Normal Na+/K+ Pumping. In this 
condition, enough ATP is generated, so the Na
+
/K
+
 pumps function normally and they maintain 
the electrochemical gradient. GluTs are able to use the electrochemical gradient and clear the 
11 
 
extra Glu from the synapses. B) Malfunction of Na+/K+ Pumping.  When there is a depletion of 
ATP, the Na
+
/K
+
 pumps are not able to function correctly, which disturbs the maintenance of the 
electrochemical gradient around the cell. Thus, the GluTs’ function is disturbed are they are not 
able to function very well, leading to Glu accumulation in the synapse and excitotoxicity.  
 
e) Excessive glutamate stimulation and excitotoxicity may engage a 
number of cell death pathways 
 
Though acute cell swelling and death is prevalent at the core of the brain area affected by 
stroke, there is in fact a range of different kinds of cell death that are observed in excitotoxicity, 
depending of the intensity of the insult in each affected area. The cell swelling and burst 
described above is one of these kinds of cell death, and it is called necrotic cell death. Necrosis is 
result of severe insult which causes the sudden death of the cell. Previously, it was believed that 
necrosis is a disorganized, uncontrollable death (seen in both brain neurons and in other cell 
types throughout the body); however, recently researchers showed that necrosis is not necessarily 
uncontrollable, as it may result from a combination of several signaling pathways. For example, 
some forms of regulated necrotic cell death seen in both neurons and other cells became known 
as necroptosis or parthanatos, depending on the specific pathways used 
21,22
.  The burst of 
neurons during necrosis further damages the surrounding neurons, for two reasons: A) there are 
high concentrations of Glu in the cytoplasm, as it is a common amino acid used in all cells for 
normal metabolism. The released Glu can now damage neighboring neurons. B)  The release of 
cell content triggers an inflammatory response that exacerbates tissue damage. It is yet unclear 
what the contribution of these processes is to excitotoxicity, but so far clinical trials aimed at 
blocking these pathways failed to protect from ischemic damage 
23
. 
12 
 
Further away from the core of the affected area, where blood supply is partial and GluT 
malfunction is not as dramatic and acute, the neurons exposed to this less intense damage have 
more time to fight against these injuries or prepare themselves. To avoid the toxicity and 
propagating damage associated with necrosis, dying cells that have time to prepare for their 
demise will commit a well-orchestrated and less damaging cell suicide called program cell death  
or  apoptosis 
4
.  This kind of programmed cell death is coordinated, energy-dependent and works 
through a process involving a group of cysteine proteases called “caspases”. There are two major 
signaling pathways in apoptosis: extrinsic pathway and intrinsic pathway. The extrinsic pathway 
of apoptosis is initiated by activating cell death receptors such as the FAS receptor or Tumor 
necrosis factors (TNFs). After activation, this receptor binds to the Fas-Associated protein with 
Death Domain (FADD) and then recruits procaspase 8. This complex is called death-inducing 
signaling complex (DISC) 
24,25
. At the DISC the caspase 8 is cleaved and activates pro-apoptotic 
proteins: it binds or it activates the executioner caspases 3, 6, and 7 
24,25
. 
The intrinsic pathway of apoptosis is switched on by activating one of the pro-apoptotic 
BCL-2 family members in the outer member of mitochondria. By activation of these BCL-2 
family members, members of two different groups of proteins (pro-apoptotic or anti- apoptotic) 
can move from the cytosol to the outer-member of mitochondria. After activation of pro-
apoptotic proteins such as Bad, Bax, and Bid, these proteins oligomerizes, forming a pore in the 
mitochondria outer-membrane and thus release of cytochrome c. Later on, cytochrome c binds to 
Apaf-1, which oligomerizes together with pro-caspase -9 to produce the apoptosome. Following 
apoptosome formation, oligomerized caspase-9 is turned on, and it activates executioner 
caspases 3, 6 and 7 
24,25
. 
13 
 
Apoptosis usually happens during development to help control the number of specialized 
cells. The morphological characteristics of apoptosis include shrinkage of the cells, denser 
cytoplasm, packaged organelles, condensed DNA, and DNA laddering 
21,26
.  There are several 
differences between necrotic cell death and apoptotic cell death. One of the important differences 
is that there is no spillage of cell contents and no inflammation that occurs during apoptosis. 
A third kind of cell death is called autophagy. Autophagy has a dual function: it is 
involved in both cell survival and cell death.  Autophagy usually helps cell survival in stressful 
conditions or starvation, by degrading or recycling some of the macromolecules such as 
ribosomes and endoplasmic reticulum fragments 
27
. However, in some cases, autophagy is used 
as a secondary mechanism of programmed cell death 
28
, in which it displays a distinct 
morphology, lack of condensed chromosomes, and production of vacuolization 
21
. Importantly, 
there is cross talk between autophagy and the other cell death programs (necrosis and apoptosis). 
For example, there is cross-talk between the apoptosis regulatory protein Bcl-2 and the 
autophagy regulator beclin 
28
. There is also cross-talk between autophagy and necrosis, as seen in 
studies that showed that inhibition of kinases receptor-interacting protein 1 (RIP1) and RIP3 
(which are two proteins that involved in necroptosis), decrease the autophagy 
27
. 
f) Excitotoxicity plays a major role in neuronal damage in stroke and a number 
of progressive neurodegenerative diseases: 
 
Stroke is the fifth leading cause of death and it is the major cause of disability in the United 
States 
29
. Each year, 80,000 of people have a stroke in the United States and majority of these 
patients are over 65 years old. The percentage of African Americans who die from stroke in mid-
life is much higher than the Caucasian population; in addition, stroke is more prevalent in 
14 
 
women than  men 
20,30,31
.  There are two kinds of strokes: hemorrhagic and ischemic. The 
majority of stroke cases (87%) come from ischemic stroke. Ischemic stroke is a result of 
blockage of blood vessels, typically due to a blood clot; thus the lack of blood flow causes an 
energy shortage in the brain areas that are normally nourished by the specific blood vessel 
20
. 
The center of the area that stroke occurs is called core area. The cells in this area go through 
acute, severe, and irreversible injury and at the end necrotic cell death. In contrast, damage in the 
surrounding area (Penumbra) is more moderate, and cells can survive from the insult a little 
longer, and then some of them die from apoptosis while others recover and achieve long-term 
survival  
4
 (Figure 6) . One of the most effective ways of therapy for ischemic stroke is 
thrombolysis therapy (opening of blood clot using a drug). However, the disadvantage of this 
therapy is that it can only be used in the first two hours after ischemic stroke onset. This is 
because ischemic stroke causes a gradual deterioration of the blood capillaries, so that 
anticoagulation / thrombolytic treatment at this later time causes hemorrhagic stroke, which also 
called hemorrhagic transformation, in the patient that initially presented with ischemic stroke 
32–
34
. 
 
Figure 6 The affected areas during and after the stroke 
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Figure 6: The affected areas during and after the stroke. The red area represents the core area 
where the stroke initiated and the cells die by necrosis. The penumbra area is affected as a result 
of excess amount of glutamate that come from core area, so they have more time to sense the 
upcoming insult and they die from apoptosis (Figure is adopted from 
4
).  
 
In addition to the direct involvement of excitotoxicity as the most prominent trigger of 
neurodegeneration in brain ischemia, excitotoxicity is also seen as a contributing factor to cell 
damage in many other neurodegenerative diseases that are triggered by other factors. Indeed, 
excitotoxicity is considered a common neurodegenerative process in many neurological diseases, 
as neuronal damage spiral down and out of control, at the advanced stages of the disease. 
Nonetheless, beyond these common factors seen in many neurological diseases, excitotoxicity 
seems to have a special contribution to certain neurological diseases. 
I) Amyotrophic Lateral Sclerosis (ALS): 
 
ALS is a fatal adult-onset neurodegenerative disease that causes death between 3-5 years 
after diagnosis. ALS is one of the main neurodegenerative diseases in which motor neurons 
degenerate in the brain stem, motor cortex, and spinal cord, leading to difficulties in speech, 
swallowing and breathing. ALS is seen more in men than women and highly prevalent in the 
West Pacific 
35,36
. There are two forms of ALS, a familial form (10% of cases) and a sporadic 
form (90% of cases) 
37
. ALS is a result of many factors such as oxidative stress, apoptosis, 
inflammation, proteins aggregation, and excitotoxicity. In both sporadic and familial ALS, as 
well as in a number of mutation triggered-ALS animal models, GluT expression in astrocytes 
declines dramatically relatively early in disease progression 
38
. As stated previously, the 
malfunction of glutamate transports causes the accumulation of glutamate in the extracellular 
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space and therefore, it causes over-activation of glutamate receptors and influx of Na
+
 and 
Ca
2+
into the postsynaptic cell. The excess amount of Na
+
 and Ca
2+
 causes over-excitation of cells 
and in the end it causes necrotic cell death 36. 
II) Alzheimer’s disease: 
 
  Alzheimer’s disease (AD) is a neurological disease that involves dementia and memory 
lost. AD was first discovered by Alios Alzheimer in 1907 and it is the seventh cause of death in 
the United States 
39
. There are two hallmarks for recognizing the AD: extracellular accumulation 
of β-amyloid (Aβ), and intracellular neurofibrillary tangles of a microtubule binding protein 
called tau 
40
. Aβ is produced from APP precursor protein by shedding of an extracellular 
segment, a process mediated by the enzymatic activity of the β-secretase complex. Aβ causes 
cell damage in a number of ways that involve Glu signaling. Prolonged activation of the NMDA 
receptor causes a change in the relative activity level of α-secretase (which processes APP in a 
different way) to β-secretase, and more Aβ production. In return, part of the toxicity of Aβ and 
its oligomeric aggregates is mediated by over-activation of NMDA-Rs, so that Aβ makes the 
neuron more sensitive to glutamate.  Aβ also binds to the lipid membrane and produces an 
oligomeric pore in the neuronal lipid membrane which increases permeability to Ca
2+  41,42
  and at 
the end causes excitotoxicity.  Another toxicity mechanism is that Aβ might disturb the functions 
of ATPase and glutamate transporters. Ultimately, the over-activation of GluRs and influx of 
Ca
2+
 activate many pathways such as PKA, MAPK, and AKT 
43
,
  
resulting in excitotoxicity. 
Activation of Aβ and NMDA together causes the over-activation of ER and thus increase Ca2+ 
release from intracellular stores and disrupt its homeostasis, which may later cause the 
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excitotoxicity 
43
.  Another connection between Aβ and Glu signaling is through the cellular prion 
protein (PrP
C
), which is an anchor protein that is able to bind to many extracellular proteins. Aβ 
binds to the NMDA receptors through the C terminal and affects the kinetic of glutamate 
receptor-mediated currents. The N-terminal site has a region that is able to bind to Aβ proteins. 
Therefore Aβ binds to the NMDA receptor through PrPC , and it causes a decrease in the normal 
rate of desensitization of NMDA receptors; thus Aβ uses several mechanisms to enhance 
entrance of excess of amounts of Ca
2+
 into the cells and at the end, it causes excitotoxicity and 
cell death 
43–45.  
 
III) Huntington’s disease: 
 
Huntington’s disease (HD) is a dominant, autosomal genetic disease. HD appears often in 
middle age but it can appear at any age 
46
.  The symptoms include irregular involuntary 
movement, and dementia 
46–49. HD is result of mutation in the gene HTT which codes for the 
Huntington protein. The HTT gene contains repeated triple nucleotides (CAG) that in healthy 
individuals is repeated 35 times; however, when there is a mutation, the stretch of (CAG) 
expands, and can be repeated 120-150 times 
49
. CAG is a codon for glutamine; thus the 
trinucleotide repeat makes a chain of glutamine, denoted poly glutamine (poly Q) 
46
.  HTT is 
subjected to break down by a lot of proteases and one of these proteases is calpain. Over 
expression of HTT in mice increases release of Glu and over-activation of NMDA-R increases 
the Ca
2+
 concentration inside of the cell. Therefore, when the caplain is activated and begins to 
break down the HTT protein, it causes overstimulation of GluRs, and at the end excitotoxicity 
18 
 
12,46,47
.  There are several lines of evidence that show the relationship between the HD and 
excitotoxicity. The first sign is an increase in the concentration of Glu as a result of malfunction 
of glutamate transporters. There is also evidence that shows increase in the activity of NMDA-R. 
The last thing that showed the involvement of excitotoxicity in HD is malfunction of 
mitochondria, which prevents the mitochondria from buffering  the intracellular Ca
2+
 so that it is 
not able to produce enough ATP 
49–51.  
g)  Susceptibility to excitotoxicity is modulated by several pathways, 
including cellular aging and insulin signaling 
 
  The involvement of excitotoxicity in a range of acute and chronic neurological diseases 
led to an active search to find a way to prevent cell death as a result of excitotoxicity 
52
. A 
popular strategy in clinical trials, supported by early success in animal models, was based on 
wholesale inhibition of glutamate receptors with antagonists; however, inhibiting glutamate 
receptors, did not decrease the neuronal cell death; furthermore, inhibiting GluRs caused high 
rate of morality in patients. These disappointments led to the surprising conclusion that 
glutamate receptors are vital for neuronal survival and recovery 
53
.  This conclusion implies that 
there are specific neuroprotective, anti-excitotoxic pathways, some of which might be triggered 
by glutamate.  
Another form of neuroprotection is provided by the resilience of young neurons. It was 
shown that aging affects the rate of cell death after excitotoxicity. For example, when researchers 
compared the penumbra area of young patients and elderly patients who had similar damage 
from initial stroke, they observed that a larger area of the cells were able to recover in young 
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patients compared to the elderly patients 
54
 . It was further shown that the difference in neuronal 
recovery rate between old and young animals can be attributed to the cellular level. When slices 
of animal brain from young or older animals were subject to stroke simulation in vitro (by 
oxygen and glucose deprivation), the rate of their recoveries were different. The neurons in the 
brain slice from older animals have the tendency to recover much less than the cells from tissue 
of brains of younger animals; therefore, the researchers conclude that cellular aging also plays a 
role in neuroprotection 
55
. The regulation of organismal aging  by the insulin signaling pathway 
was first discovered in C. elegans, where it was shown that inhibition of this pathway caused the 
worms to live longer and show more resistance to stresses 
56,57
. Researchers have shown that 
there is a relationship between the Glutamate receptors and insulin signaling pathway. Some of 
the effects of insulin signaling involve excitotoxicity-triggered apoptosis 
8
, while others involve 
control of glutamate receptor surface expression. For example, pervious research showed that 
insulin plays a significant role in the trafficking of AMPA receptors in dendrites, which effects 
long term depression (LTD) 
58,59
. In another set of experiments, Man et al. were able to show that 
there is a functional and physical connection between PI3K and AMPA receptors and that 
cooperation of these two pathways effect the production of Long Term potentiation (LTP) 
60
. It is 
therefore important to take a closer look at the molecular components of the insulin signaling 
pathway. 
 h) The Insulin Signaling Pathway (IIS) is a conserved cascade that 
translates extracellular signals to cytoplasmic & nuclear response. 
  
Although insulin is best known for its ability to regulate sugar metabolism in the body, 
insulin also has a profound role in modulating neuronal activity
61,62
 in the CNS and the course of 
neurodegenerative diseases 
62,63
. Insulin can pass through the Blood Brain Barrier (BBB) through 
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specialized carriers 
64
, enter the brain, and bind to insulin receptors. The insulin receptors are 
concentrated selectively in specific areas in the brain such as hypothalamus and cerebral cortex 
65
. Hypothalamus is the part of brain that is responsible for several functions, such as endocrine 
regulation, metabolic system, reproduction, and circadian rhythms. Glutamate is the main 
excitatory neurotransmitter that middle hypothalamus neurons use to communicate with each 
other 
66
.  Glutamatergic synaptic transmission in  hypothalamus contributes  to insulin-induced 
sympathoexcitation 
67
, demonstrating important interactions between these two signaling 
pathways.  The insulin signaling pathway is involved in many neurological diseases such as AD, 
PD, and HD. The insulin signaling pathway also plays a major role in learning and memory and 
also aging 
29
.  
Insulin signaling is mediated by a signaling cascade that is highly conserved from nematodes 
to humans 
68–70. Briefly, Insulin/IGF binds to insulin receptors and allows the recruitment of 
insulin receptor substrate (IRS). IRS binds to phosphatidylinositol-4-5-biphosphate 3-kinase 
(PI3K) which then changes the signaling lipid PIP2 to PIP3. PIP3 is able to recruit several 
Ser/Thr kinases to the plasma membrane and helps to activate these kinases. PDK-1 is one of the 
kinases, which is brought up to plasma membrane. PDK-1 then activates AKT, which is also 
brought up to the membrane by PIP3. AKT phosphorylates FOXO transcription factor and 
inhibits the translocation of FOXO from cytoplasm to the nucleus. (Figure 7).  Since the details 
of insulin signaling are important for this thesis, it is worth examining the steps of this cascade in 
more detail. 
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I) Insulin signaling starts with binding to its receptors: 
 
Insulin receptors (IRs) are part of a family of Receptor Tyrosine Kinases (RTKs)
71
 The 
subfamily of RTKs  to which insulin receptor belongs contain two different isomers (IRs) and 
also the IGF-1 receptor
72
.  Ligand binding to insulin receptors causes subunit dimerization, 
cross-subunit auto-phosphorylation, and recruitment of IRS, an adapter protein. IRS contains 
several domains, including a PH-PTB domain (important for binding phosphatidylinositol 
lipids), and a SH2 binding domain (responsible for binding to the phosphotylated tyrosine 
residues such as the one in the autophosphorylation site of the IR)  
73
.  
II) Phosphatidylinositol 3-kinase (PI3K)  PDK-1 AKT FOXO: 
 
PI3K Phosphatidylinositol 3-kinase (PI3K) adds a phosphate to phosphoinositides found in 
the cell membrane. The best studied phosphoinositide is PI(3,4)P2, which can be broken down by 
G-protein activated phospholipase C (PL-C) into the second messengers IP3 and DAG. In 
addition to the ability of the cell to break down PIP2, the cell can alternatively add yet another 
phosphate to the inositol ring, and create PIP3. This function is mediated by the enzyme PI3K.  
There are three classes of PI3Ks (I, II, and III).  Each of these classes produces different 
phosphoinositides and each of these classes also contains some subfamilies. Class I of PI3K is 
studied the most and there are four different subfamilies in vertebrates and only one kind in C. 
elegans and Drosophila  
74
. The class I PI3K is the only one that produces phosphotidylinositol-
3, 4, 5-triphosphate (PIP3), which is also a second messenger that activates several pathways. 
PIP3 then serves as an anchor to recruit phosphoinositide dependent kinase-1 (PDK-1) and 
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Protein kinase B (AKT) to the membrane by binding to the PH domain of these proteins; PIP3 
brings these proteins to the membrane and thus activates them. When PIP3 binds to the PH 
domain of AKT, it changes the conformation of AKT; thus the PDK-1 can phosphorylate and 
activate AKT 
70
.  AKT phosphorylates many different proteins including Forkhead-type 
transcription factor (FOXO).  There are four different kinds of FOXO in the mammals, FOXO1, 
FOXO3, FOXO4, and FOXO6.  AKT is able t/o phosphorylate three different sites of FOXO and 
by doing so changes its conformation, allowing it to bind to the regulatory protein 14-3-3. 
Binding of FOXO to 14-3-3 prevents FOXO from entering the nucleolus 
75
 (Figure 7).  FOXOs 
have diverse functions in the cell. They are involved in apoptosis, cell cycle, cell stress, and also 
longevity. These specific functions are determined by post-translational modifications. These 
post-translational modifications that FOXO can undergo are phosphorylation, ubiquitination, and 
acetylation 
76
. 
 
 
 
 
 
 
 
 
 
 
Figure 7 Insulin Signaling Pathway 
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Figure 7:  Insulin Signaling Pathway. This pathway was first discovered in C. elegans 
is involved in many processes such as in longevity, cell division, and metabolism and cell stress 
resistance. 
 
I) The Cytohesin/GRP-1 complex is a regulator of Insulin/IGF Signaling 
pathway (IIS): 
 
  Given the critical importance of insulin, it is not surprising that this cascade is subjected 
to upstream regulation, but our understanding of this regulation and its possible effect on 
different modes of insulin signaling is incomplete. Previous investigation of the metabolic effects 
of insulin in mammalian liver cells and its growth hormone-like effect on fly body size showed 
that a protein complex that contains the protein Cytohesin is a key regulator of the IIS pathway  
77–79. The Cytohesin complex contains three main proteins: Cytohesin, Arf and PIP5K. As a 
result of activation of this complex, PIP2 is produced, which is a substrate for PI3K. 
80
. Two 
previous studies that were done in Drosophila and mammalian cells showed that Cytohesin 
affects the IIS 77,78.  In one of the studies, Fuss et.al (2006) screened for mutations that 
phenocopy the effect of insulin signaling mutations in the fly, i.e., reduced body size. Using 
epistasis analysis they showed that a mutation in Steppke (found to encode a homolog of 
Cytohesin) in Drosophila acts upstream of the IIS’s PI3K to regulate body size. Furthermore, 
they find that this mutation causes Akt to be under-phosphorylated and FOXO to enter the 
nucleus; therefore, they conclude that the Cytohesin complex acts upstream of the IIS pathway
77
 
In addition, Lim et.al showed that activation of the Cytohesin complex enhances activation of 
PIP3 synthesis and the activation of IIS pathway 
79
. 
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I) Cytohesin: 
 
Cytohesins are Guanine Exchange Factors (GEF), which are able to catalyze the exchange of 
GDP to GTP on the small G-proteins known as Arfs. Cytohesins are involved in many cellular 
processes such as cell adhesion, cytoskeleton dynamics, the IIS pathway in Drosophila and 
mammals,  and endocytic trafficking 
77
. There are four different Cytohesins in the mammals 
(Cytohesin1-4) and there is one in Drosophila and in the nematode. Cytohesin consists of several 
domains, two of which are: a) Sec 7: responsible for exchanging GDP to GTP, and b) PH domain 
which binds to Phosphatidyl Inositol (PI). The other two domains of cytohesin are the C-terminal 
helix (CtH), which overlaps with the other domain, Polybasic domain (PBR)
81
  (Figure 8).  
 
 
Figure 8 Different domains of Cytohesin.  Cytohesin contains four domains 
Figure 8:  Different domains of Cytohesin.  Cytohesin contains four domains.  a Sec7 
domain plays a role in exchanging GDP to GTP in Arfs, a PH domain helps Cytohesin to bind to 
the membrane by binding to the PI, a Coil-Coil domain for interaction with scaffolding proteins, 
and a C-terminal polybasic domain that contains phosphorylation sites (This figure is adopted 
from Hayallah, Indian J Pharm Sci. 76(5): 387–400, 2014). 
 
Cytohesin is regulated by two intra-molecular interactions that cause autoinhibition. 
There are several different ways that Cytohesin becomes autoinhibited (Figure 9). In the first 
intramolecular autoinhibitory interaction, the linker between the PH domain and Sec7 domain 
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(CtH) plays a role as a psuedosubstrate to inhibit the Sec7. The second intramolecular interaction 
involves the coiled-coiled section of N-terminal of the protein, 
83
. Basic activation of cytohesin is 
mediated by binding of GTP-bound Arf of a certain subtype (Arf6) to the PH domain, allowing 
cytohesin to expand the repertoire of active Arf subtypes, creating a positive feedback loop to 
activate Arfs 
84
. The activation of Cytohesin is then further stabilized by two phosphorylation 
reactions: phosphorylation by PK-C mimics the activation by GTP-bound Arfs. Additionally 
AKT phosphorylates Cytohesin on a conserved residue, theronine 276  in the PH domain 
83
. 
Therefore, Cytohesin activation further produces a positive feedback loop through AKT. 
However, if there is a deletion in the Sec 7 domain, the activation of ARF by Cytohesin is 
prevented and production of PIP2 is blocked. When there is decrease in the production of PIP2, 
the IIS pathway will be inhibited, which affects the activation of AKT and prevents the positive 
feedback loop.   
 
 
Figure 9 Autoinhibition of Cytohesin 
Figure 9:  Autoinhibition of Cytohesin. AKT can phosphorylate threonine in PH domain and 
relieve the autoinhibition. The second part of autoinhibition is relieved by phosphorylation of 
CtH by PKC (the figure is adopted from 
83
). 
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Cytohesins are connected to a scaffold protein called tamalin/ GRP-1 association scaffold 
protein (GRASP) 
85–87. Tamalin contains several domains: a PDZ domain, a leucine zipper 
domain, and a proline-rich domain. By binding to such a multi-domain protein, Cytohesin is able 
to connect directly with the postsynaptic receptors such as mGluR1 through the PDZ domain and 
it also can be connected  indirectly to the NMDA receptor and AMPA receptor through the post 
synaptic scaffolding protein PSD95  
88,89
 (Figure 10). PSD95 plays a significant role in the 
AMPA trafficking and it was shown that over-activation PSD95 has a significant effect on the 
AMPA receptor response in hippocampus slices 
88,89
 . 
 
Figure 10 Tamalin is a bridge between GluRs and Cytohesin/GRP-1 
Figure 10:  Tamalin is a bridge between GluRs and Cytohesin/GRP-1. The scaffold protein 
tamalin (GRASP) connects the NMDA receptor  and mGluR-1  to Cytohesins 
88
.  
II) ADP Ribosylation Factor (ARF):  
  
 ADP ribsolyation factors (ARFs) are small G proteins that are members of the Ras family. 
There are three classes of ARFs. Class I contains ARFs 1-3, class II includes ARF4-5, and Class 
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III includes ARF6. ARFs are involved in cell migration, vesicular trafficking, and cell division. 
They are activated by Cytohesins and are able to activate lipid kinases, and phospholipase D, 
and  recruit cargo proteins 
81,84,90
.   One of major proteins that is activated by ARFs is PIP5K, 
which produces PIP2 
79
. 
III) Phosphatidylinositol 4-phosphate 5-kinases (PIP5K): 
 
PIP5K, which turns phosphatidylinositol 4-phosphate (PI(4)P) to phosphatidylinositol 
4,5-bisphosophate PI(4,5)P2 
91
, is another member of the Cytohesin complex. PIP5K has three 
different isomers: PIP5kα, PIP5kβ and the last PIP5Kγ. Various cellular stimuli, which include 
neurotransmitters, hormones and growth factors, can activate PIP5K to produce PIP2; PIP2 has 
many functions in the cell 
91,92
.  PIP2 is hydrolyzed by Phosphoinositide phospholipase C (PLC) 
to produce diacyglycerol (DAG, stays in the membrane) and inositol 1,4,5-trisphosphate (IP3, 
released to the cytoplasm). Cytoplasmic IP3 binds to IP3 receptor/channels on the surface of the 
endoplasmic reticulum (ER) and allows Ca
2+
 release from the ER, causing an increase in 
intracellular Ca
2+
 concentration. PIP2 is also the substrate for the previously mentioned type-I 
PI3K. PIP2 also plays a role in cell development and programmed cell death (apoptosis) 
93
. 
The previous sections provide detailed information on a number of critical signaling 
cascades that control excitotoxic neurodegeneration and insulin-regulated susceptibility to cell 
stress. However, this description also indicates an inherent difficulty in the analysis of these 
cascades: many of the critical mediators of signaling come in a number of redundant versions, so 
that knock-out (KO) of single of gene encoding derivatives of these key enzymes/factors is 
ineffective, while combination KO of all its forms is often lethal. Moreover, intricate lines of 
crosstalk connect different cascades into a web that is difficult to tease apart and determine what 
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is a primary core effect and what is a secondary or tertiary side effect. Therefore there are many 
obstacles to studying molecular and cellular signaling events that affect and regulate 
excitotoxicity in mammals. It is therefore beneficial to use a model organism that has simpler 
signaling systems, and is yet able to elucidate excitotoxicity. Thus, we decided to use the 
nematode C. elegans to elucidate IIS function and regulation in excitotoxicity. 
j) C. elegans research offers strong tools and simplified signaling cascades 
that at their core are comparable to mammals: 
 
There is extensive homology between human  and C. elegans genomes, and  basic 
mechanism of many of diseases and molecular processes were discovered in the C. elegans and 
found to be similar to their parallel process in mammals 
94–97
. Diseases such as depression, 
Alzheimer’s disease, and diabetes can be studied in C. elegans, and many molecular details of 
critical cellular processes such as Insulin signaling pathway, apoptosis, and RNAi were first 
discovered in the C. elegans 
95–97
. 
There are many effective research tools that can be used to study C. elegans. For 
example, the full sequence was determined for the in C. elegans genome, and gene function can 
be easily studied by knock down (RNAi) or by gene deletion / knock out (many mutant strains 
are available for free from a common genetic bank that distributes KOs, point mutants, and 
transgenic strains). C. elegans can easily be cultured; they have a high reproduction rate and 
short lifespan; thus, many samples and different generations can be studied. Since these worms 
are transparent, different processes can be studied in intact live animals, using fluorescence 
markers in vivo, including processes such as neurite growth or degeneration. Even though this 
organism is very simple, it still includes important types of tissues and organs. Importantly for 
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us, C. elegans has a nervous system which contains 302 identifiable neurons that fall into all the 
major neuronal categories 
94,98
. Animals can be put in different stress condition such as over-
population, elevated temperature, and lack of food. During stress, their larva can go into a 
durable and resilient form called dauer, and return back to normal development when conditions 
improve (figure 11), making worm maintenance in lab very easy 
99–101. 
The simple life cycle and maintenance of C. elegans in the lab, together with its ability to 
self-fertilize, enable animals with strong mutations that would be fatal in other animals to be 
viable in nematodes. This resilience allows us to establish mutant strains that harbor critical 
mutations, but are viable and can be easily studied. Moreover, the genome of the nematode 
contains much less redundancy of genes encoding key factors in signal transduction (i.e., it does 
not contain several genes encoding slightly divergent versions of the same receptors, scaffold 
proteins, enzymes, and transcription factors, just one of each). Therefore, a mutation in a key 
enzyme or factor is likely to have a prominent effect without compensation from similar versions 
of the protein encoded by other genes. Furthermore, cross talk between signaling pathways is not 
as sensitive as in mammals, making the difference between a primary effect of a mutation and a 
secondary or tertiary side effect more clear. In spite of this reduced redundancy and complexity, 
the most important part of, or the core of a signaling cascade, is usually astonishingly well 
conserved from nematodes to humans. This observation allows us to make the reverse deduction  
that the conserved core of a signaling cascade can many times be detected by virtue of its 
conservation from nematodes to humans. In this notion we assume that non-core parts of the 
signaling pathway had the opportunity to diverge during evolution, while the essential core of the 
pathway remains conserved (similarly to the logic of alignment of protein sequences, where the 
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core active domains are highlighted by their conservation).  Lastly, the large body of data and 
reagents (such as numerous widely-available mutant strains with carefully documented 
phenotypes) make the screening of candidate genes very effective. In sum, C. elegans offers a 
particularly strong set of tools and benefits that make it ideal for the analysis of complex 
signaling cascades. A specific cascade which is particularly important to our research and is well 
conserved in the nematode is that triggered by the neurotransmitter glutamate. 
 
 
Figure 11 Life-cycle of C. elegans. 
Figure 11.  Life-cycle of C. elegans.  From inside the eggs through adult. 
 http://www.wormatlas.org/ver1/handbook/anatomyintro/anatomyintro.htm 
k) Role of Glutamate Signaling Pathway in C. elegans:  
 
Although C. elegans, like other invertebrates, use glutamate as both an excitatory and 
inhibitory neurotransmitter, the prominent extent of use of glutamate in central excitatory 
synapses in nematodes is unusual for an invertebrate. Indeed excitatory glutamate signaling 
mediates most of the communication between the sensory neurons and their postsynaptic 
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partners  the command (i.e., decision making) interneurons, and further downstream the neuronal 
circuits to mediate behavioral responses 
102,103
. The molecular building blocks that make up 
excitatory signaling by the neurotransmitter glutamate are highly similar between mammals and 
C. elegans. There are ten genes encoding ionotropic glutamate receptors in the C. elegans; eight 
of them (GLR-1 to GLR-8) are similar to the mammalian AMPA receptors, and two are similar 
to mammalian NMDA receptors (NMR-1 and NMR-2) 
104.
 There are three metabotropic 
receptors (MGL-1 to MGL-3) in C. elegans 
105
. Glutamate is removed from synapses by 
glutamate transporters in C. elegans. There are six Glutamate Transporters (GLTs) in the C. 
elegans (GLT-1; GLT-3-GLT-7) 
106
. Because GLT-1 and GLT-4 are expressed close to 
synapses, they may collect the Glu from the synaptic area; therefore, this group of GLT is called 
proximal GLTs. In contrast, GLT-3, GLT-6 and GLT-7 are expressed in the excretory canal cell 
and the assumption is that this group transfers the Glu from the body fluid to the excretory canal 
cell to be disposed; thus these GLTs are called distal GLTs (glt-5::gfp expression is very weak 
and could not be determined with certainty).  GLT-3 is one of distal Glutamate transporters that 
plays a significant role in clearance of Glu. Glutamate synthesis in the C. elegans is not very well 
studied; however, it is shown that the C. elegans use pyruvate carboxylase (pyr-1) ( it is an 
enzyme that produces  oxaloacetate, which is an important component of the Krebs cycle) 
107
 to 
produce Glu. Nematodes have four kinds of glutamine synthesis (gln-1-3 and gln-5) and also 
they have three different kinds of glutaminase (glna-1-3). In the same way as seen in mammals, 
in C. elegans, Glu is packed in the glutamate vesicular by glutamate vesicular transporter, such 
as eat-4 to be transported to the active zone and released into the synapse. Then, as mentioned in 
above, glutamate is reuptaken by the glutamate transporters 
108,109
 . 
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l) Excitotoxicity in C. elegans: 
Since glutamate signaling is similar in C. elegans and mammals and C. elegans also 
provides a very valuable tool to study the biological pathways, we decided to use C. elegans as 
our model to study excitotoxicity.  Mutation in any of the six glt genes (individually and a few of 
the possible combinations) did not result in discernable neurodegeneration, prompting us to 
search for conditions of increased sensitivity that might be more susceptible to 
neurodegeneration.  Previously, it was shown that the over-activation of Gαs (using a transgene 
labeled nuIs5)  caused a low level of necrotic cell death in neurons, a condition which is not 
dependent on [Glu] 
110
. However, by combining the over-activation of Gαs with deletion of glt-3 
(Δglt-3), we were able to generate on excitotoxicity model in C. elegans model (Figure 12). In 
our model, we were able to show stronger necrotic cell death, which is Glu dependent and it is 
very similar to the mammalian condition 
106,111
 (Figure 10 a,b). Interestingly, combining nuIs5 
with either glt-1 or glt-4 mutations did not result in enhanced neurodegeneration, underscoring 
the importance of the distal GluT glt-3 in maintaining glutamatergic signaling in the nematode. 
To confirm that glt-3 is responsible for the necrotic cell death, we reintroduced wild type glt-3 
(glt-3
+
) and we were able to observe that the number of necrotic cell death was reduced to the 
basal level. In contrast to our view that neurodegeneration in nuIs5 is Glu independent, Berger et. 
al initially suggested that over activation of Gαs (Gαs*) in postsynaptic neurons by the 
nuIs5[Pglr-1::Gαs*;Pglr-1::GFP] transgene causes the glutamate dependent neurodegeneration, 
because a mutation in  eat-4 (but not a mutation in glr-1) causes a small reduction in the number 
of neurodegenerating neurons 
110,112
. The contradiction between the small effect of eat-4 and the 
lack of effect of glr-1 was suggested by Berger et al. to be the result of the use of other GluRs in 
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the degenerating cells. However, later on, when we inhibited all three of the major GluRs in 
these cells (using a combined glr-1; glr-2; nmr-1 KO) we were not able to observe any 
difference in the number of dying neurons in comparing nuIs5 vs glr-1; glr-2;nmr-1;nuIs5 
animals. Therefore, we conclude that the neurodegeneration mediated by nuIs5 alone is not Glu 
dependent, and the decrease that was observed by Berger et al. in the eat-4 mutants is likely to be 
the result of the feeding defect in these eat mutants (as starvation is known to partially protect 
the worn from necrotic cell death)
111
. In contrast, the additional extensive necrosis seen in these 
neurons upon addition of glt-3 KO to the nuIs5 transgene is completely Glu dependent, as 
demonstrated by the observation that glr-1;glr-2;nmr-1 KO reduces neurodegeneration in glt-
3;nuIs5 animals back to the background level observed in nuIs5 single mutants. Since the 
extended necrotic neurodegeneration seen in glt-3;nuIs5 animals is triggered by the KO of the 
GluT gene glt-3 and is eliminated by KO of the GluRs expressed in these neurons, we consider 
this condition as a bona fide model of excitotoxicity. 
 
a) 
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b)  
   
 
Figure 12 A strain carrying a mutation in glt-3 and the nuIs5 transgene increases necrosis cell death 
Figure 12. A strain carrying a mutation in glt-3 and the nuIs5 transgene (which contains an 
integrated [Pglr-1::Gαs*;Pglr-1::GFP] construct)  increases necrosis cell death. The neurons 
that normally express glr-1 are visualized with GFP because nuIs5 is transgenic for Pglr-
1::gfp. a)  DIC picture of Δglt-3;nuIs5 shows necrotic neurons in the head (marked by red 
arrows). b. Fluorescence picture of Δglt-3;nuIs5 shows the glr-1 expressing neurons labeled with 
GFP. 
 
  Using this model of nematode excitotoxicity we showed that excitotoxic 
neurodegeneration involves a number of Ca
2+
 sensitive proteins. Calreticulin is a Ca
2+
 “sponge” 
expressed in the ER and its presence is needed for cell death. Triggering neurodegeneration also 
requires calcineurin 
111
. The dependence of nematode excitotoxicity on the atypical adenylyl 
cyclase (acy-1) is particularly interesting, since this is a type-9 adenylyl cyclase (AC9) that is 
inhibited by Ca
2+
 through the action of calcineurin (while most adenylyl cyclases are directly or 
indirectly stimulated by Ca
2+
). Calcineurin is a calmodulin-dependent serine/threonine protein 
phosphatase that is involved in many different cellular processing in different cells. In 
mammalian neurons calcineurin is known to dephosphorylate GluRs, leading to reduced single 
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channel activity. As in mammals, in nematodes calcineurin is pluripotent, and its effects  include 
changes in egg laying, behavior, and aging 
113
. Based on the mammalian studies on the effect of 
calcineurin on GluRs and the apparent synthetic lethality of cnb-1 mutations (affecting a 
regulatory subunit of calcineurin) in the excitotoxic background, we suggest that calcineurin has 
two major functions in our model:  A) calcineurin inhibits adenylyl cyclase type 9/acy-1.  B) 
calcineurin dephosphorylates and reduces the activity of AMPA receptors. In our model, over 
activation of Gαs overcomes these functions; it causes adenylyl cyclase type 9 to keep activating 
PKA, leading to continuous phosphorylation of the nematode’s Ca2+ permeable AMPA receptors 
and causing cells to be hyper-potentiated. The combination of potentiated GluRs (due to 
phosphorylation) and hyper-stimulation by excessive Glu (due to GluT KO) results in GluR 
hyperactivation and letting excessive Ca
2+
 enter the cells 
111
. A similar scenario could take place 
also in mammalian ischemia, since hypoxia/ischemia is regularly accompanied by mass secretion 
of AMP and Adenosine, causing hyper-activation of Gαs-linked A2A adenosine receptors, 
possibly causing GluR potentiation. As we mentioned before, lack of energy causes malfunction 
of GluTs and thus increase of [Glu] in the synapses. Excess amount of Glu now gates the hyper-
phosphorylated GluRs, causing hyper-activation of GluRs and influx of excess amount of Ca
2+
 
and Na
+
 into the cells.  The excess amount of Ca 
2+ 
inside the cell causes excitotoxicity and  
necrotic cell death 
111
  (Figure 13).  
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Figure 13 A model for excitotoxicity in C. elegans. 
Figure 13. A model for excitotoxicity in C. elegans.  a) Normal signaling. In low concentration 
of Glu and Calcineurin-mediated inhibition of AC9, AMPA receptors mediate only minimal 
currents; thus the level of Ca
2+
 stays low inside of the cell. b). During excitotoxicity. High levels 
of Glu combined with over activation of Gαs will overcome the activation of calcineurin. Hence, 
PK-A keeps the glutamate receptors phosphorylated and potentiated, and thus susceptible to 
hyperactivation. The combination of GluR potentiation with their overstimulation by GluT KO-
mediated Glu surplus causes excessive Ca
2+
 influx and excitotoxicity (Figure is adopted from 
reference 
111
). 
 
These observations demonstrate that physiological and pathological Glu signaling is well 
conserved in C. elegans and can be studied with great efficiency in this model to provide new 
insights. But how about neuroprotective signaling cascades and especially the cascade that is at 
the center of this thesis, the insulin signaling cascade?   
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m) The Insulin/IGF-1 Signaling (IIS) pathway is well conserved in C. 
elegans: 
 
IIS is particularly well conserved from the C. elegans to the human. In nematodes, the 
insulin-like ligand binds to insulin receptor/DAF-2 and activates PI3K/AGE-1. AGE-1 
phosphorylates PIP2 to PIP3, which becomes an anchor for PDK-1 and AKT-1 and brings them 
to the membrane. AKT-1 phosphorylates FOXO/DAF-16 and that causes FOXO/DAF-16 to bind 
to 14-3-3/FFT-2 and prevents FOXO/DAF-16 from entering the nucleus. When IIS is 
inactivated, FOXO/DAF-16 enters the nucleus and triggers transcription of specific genes 
69,114–
116
 (Figure 14).  
Reduction of function mutation of the dauer-entry controlling genes daf-2 and age-1 also 
causes increase in longevity of non-dauer adult worms; therefore,  the IIS pathway is also called  
the aging pathway 
117,118
. However, IIS pathway does not only play a role in aging but also plays 
a significant role in cell stress resistance. Researchers were able to show that inhibition of the IIS 
pathway makes the worm highly resistant to elevated heat, heavy metal, bacterial infection and 
oxidative stress 
56,119–121. When the worms go through stress, DAF-16 translocates into the 
nucleus and activates the transcription of many stress resistance genes such as antioxidant SOD 
120
 or heavy-metal stress tolerance genes (mtl) 
122
. Many of these stress conditions are sensed by 
neurons, which express high levels of the insulin receptor DAF-2
123
, and inhibition of the IIS 
pathway causes neuroprotection and survival of neurons. We therefore suspected that the IIS 
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pathway may also play a role in excitotoxicity. C. elegans is a very good model to study these 
stresses; therefore, we decided to study the excitotoxicity and IIS-mediated neuroprotection in 
this model system 
124
. 
 
 
Figure 14 The comparison of IIS pathway between C. elegans and Mammals 
Figure 14. The comparison of IIS pathway between C. elegans and Mammals.  The figure 
lists the major components of the IIS pathway, which is involved in metabolism, development, 
longevity, and cell stress resistance. 
n) Insulin signaling plays a neuroprotective role in excitotoxicity in both 
nematodes and mammalian neurons: 
We did several studies with our collaborator Dr. Kalb to investigate the role of IIS in 
excitotoxicity in nematodes and in primary cultures of mouse spinal cord neurons and observed 
similar effects in both systems. In one of the experiments, we genetically inhibited the IIS 
pathway by using a mutant PI3K/age-1 (using the hx546 allele, carrying a reduction-of-function 
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mutation that does not affect dauer entry under normal growth conditions). We combined this 
mutation with the excitotoxicity strain and then compared the number of dying cells between the 
excitotoxicity strain ∆glt3;nuIs5 and the ∆glt;nuIs5;age-1(hx546).  We were able to observe that 
the number of degenerating neurons in the ∆glt;nuIs5;age-1(hx546) decreases significantly 
compared to the regular excitotoxicity strain. We further studied the role of the IIS pathway in 
the excitotoxicity by using a drug called Psammaphysene A (PA), which was isolated in a 
chemical screen and prevents FOXO-1 from exiting the nucleus 
125
. We were able to observe that 
by using PA, DAF-16 accumulates inside the nucleus (DAF-16::GFP was visualized by using a 
transgenic worm, Pmyo-3:daf-16::gfp). We were further able to see that as we increased the 
concentration of PA, the number of neurodegenerating neurons decreased 
124
. PA had a similar 
effect on FOXO localization and neuroprotection in mouse neurons exposed to excitotoxicity. 
These observations demonstrate that the IIS cascade controls nuclear localization (and 
therefore, presumably activity) of FOXO/DAF-16 and protection from excitotoxicity, with a 
strong conservation from nematodes to mammals. The hypothesis that stands at the center of my 
thesis is that upstream regulators of IIS identified as controlling IIS activity in insulin-dependent 
metabolism are also at work in controlling susceptibility to excitotoxicity in the nematode. It is 
therefore worthwhile examining the state of our knowledge of these factors in the nematode. 
 
o) Cytohesin complex in C. elegans: Cytohesin/Grp-1Arfs PIP5K/PPK-1 
I) GRP-1:   
GRP-1 is the closest homolog of Cytohesin in the nematodes. GRP-1 has the same 
structure as mammalian Cytohesin, including a coiled-coiled domain, sec-7 domain, a PH 
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domain, and a C-terminal domain. The roles of GRP-1 were examined in a couple of studies 
in nematodes and it was shown that GRP-1 plays a role in in asymmetric cell division in the 
neurons and it also plays a role in the apoptosis 
126,127 
II) ARFSPPK-1:   
As mentioned previously, ARFs are small G proteins divided into three different classes. 
There is one representative from each class in C. elegans. ARFs are also involved in 
vesicular trafficking 
128
 and are able to activate PIP5K 
79
. There is only one PIP5K homolog 
in C. elegans, encoded by the gene ppk-1 
129,130
. PPK-1 is localized to the plasma membrane. 
PIP5K/PPK-1 produces PIP2 which plays a role in microtubule structure, protein 
localization, and cell signaling. C. elegans ppk-1 is expressed strongly in neurons.  
Overexpression of ppk-1 during development disrupted the cytoskeleton of neurons in adult 
worms 
130
.  
In my thesis I am trying to provide evidence for the significance of the cytohesin complex 
in the regulation of nematode excitotoxicity. I also try to provide preliminary evidence to a 
possible communication between Glu and IIS signaling. This concept combines two notions 
appearing separately in the literature: 1) GluRs signaling complexes are associated with a 
protein called tamalin, which also associates with Cytohesin; and 2) Tamalin, known in that 
field as GRASP, associates with Cytohesin in insulin signaling
77,88
. To study these 
hypotheses, we investigate the effect of Cytohesin/GRP-1, ARFs, and PPK-1 on the 
involvement of the `IIS pathway in C. elegans excitotoxicity. 
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Experimental Procedures: 
 
Summary of Strains: 
 
These strains were obtained from the the C. elegans Genetics Center and the Japanese 
National Bioresource Project, or they were gifts from the producing labs. Strain used include: 
wild type  (Bristol N2), Excitotoxicity strain, glt-3;nuIs5: ZB1102 Δglt-3(bz34) IV; nuIs5[Pglr-
1::gfp-1;Pglr-1::Gαs(Q227L) V; lin 15(+)] V; zfp-1 KO: RB774: Δzfp-1 (ok554) III ; grp-1 KO: 
otIs114 Is [Plim-6::gfp; rol-6(d)] I; otIs220 Is [Pgcy-5::mCherry; rol-6(d)] IV; Δgrp-1 (tm1956) III;  
arf 1.2 KO: VC567: Δarf-1.2 (ok796) III; ppk-1 Over Expression: EG3361 (lin-15(n765ts) X 
oxIs12 [Punc-47::GFP, lin-15+] X; gqIs25 [Prab-3::ppk-1, lin-15(+)] I. (oxIs12 [Punc-47::GFP, lin-
15+] X; ced-4: MT2551 ced-4(n1162) dpy-17(e164)III; rrf-3 GRP-1 ::GFP: zdIs5; grp-
1(gm350) II; gmEx361 [Pgrp-1::gfp::grp-1]; PPK-1::GFP: : UF60: gqIs35 [Prab-3∷ppk-
1∷GFP lin-15(+)] IV; GLR-1::RFP: odls16 [Pglr-1::GLR-1::rfp];rrf-3 KO: 
NL2099:Δrrf3(pk1426);DAF-16::mCherry:IsBp_CR264[daf-16b-p::daf-16b::LAP(Spep-TEV-
mCherry)::daf-16-3’UTR::Cb_unc119]/IsB_pCR264[daf-16-p::daf-16b::LAP(Spep-TEV-
mCherry)::daf-16-3’UTR::Cb_unc-119]III. 
These C. elegans strain were grown and maintained on MYOB plates that contains OP50 
Escherichia coli bacteria in 20
0
C. Most genotypes in crosses were followed by PCR, based on 
the identification of deletion as producing shorter PCR products when amplified from genomic 
DNA.  nuIs5 was followed by the GFP marker coexpressed with the GalphaS* from P glr-1::GFP. 
This GFP signal in the interneurons can be visualized with a fluorescent stereomicroscope. The 
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ced-4(n1162) mutation was followed with the closely linked dumpy phenotype and later the 
mutation was confirmed by sequencing of the DNA. The crosses for localization were followed 
using UV optical scope. 
Analysis of Neurodegeneration: 
 
  To quantify the level of neurodegeneration , The Mano and Driscoll method was used 
111
. 
Thus, a chunk of agar with a specific strain was flipped over and placed on the cover slip and 
Nomarski Differential Interference Contrast (DIC) microscope was used to quantify the level of 
necrotic neurodegeneration.  To that end, I screened through the animals on the chunk. For each 
animal, I would identify the developmental stage (based on the structure of its vulva), and count 
the number of the swollen necrotic cells (that are similar to “vacuoles”) located in the head near 
the nerve ring or the neck (where RIG neurons are located). To confirm that “vacuolated” 
necrotic cells correspond to postsynaptic neurons, we occasionally confirmed the existence of 
Pglr-1::gfp-1. A minimum of 30 worms (with much higher numbers usually used in critical data-
points) in each developmental stage (L1-adult) were counted and the statistical significance 
between the control group and experimental group was calculated using z-test. To verify that 
phenotypes are derived from the mutations that we monitor and not from unknown background 
mutations, critical new crosses were repeated independently and analyzed independently to 
confirm our results. 
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LY294002 Treatment: 
 
  LY294002 (from LC labs) was dissolved in 100% ethanol to make the stock solution of 
25mM. 20µM of ethanol as a control and 20 µM of the stock solution were added to the 12 well 
plates that contain MYOBgar and OP50 to produce the final drug concentration of 0.2mM. After 
absorption of ethanol +/- drug, control and test worms   were placed on the plates.  After 3 days, 
the level of excitotoxicity was determined using DIC microscope. These experiments were done 
several times for optimum results. LY294002 treatment also done to determine the effect of 
LY294002 on AMPA receptor trafficking. 
Wortaminnin Treatments: 
 
Plates with different concentrations (500µM, 100µM, and 10µM) of Wortaminnin were 
prepared. Later on, worms of the excitotoxicity strain (Δglt-3(bz34) IV; nuIs5[Pglr-1::gfp-1;Pglr-
1::Gαs(Q227L) V) were placed there and then  after 2 or 3 days the level of neurodegeneration 
were observed using DIC microscope. 
SecinH3 Treatment: 
 
In this experiment, we collaborated with Dr. Kalb (U. Penn). The drug was supplied by 
Dr. Kalb, dissolved in DMSO and then  plates with the concentration of 50µM of SecinH3 was 
prepared. Excitotoxicity strain worms were placed and after two or three days the level of 
excitotoxicity was determined using DIC microscope. 
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Statistical Calculations:  
The number of necrotic cell death fluctuates because of conditions of growth, such as 
running the strain by re-chunking the strain over a long period of time, which suppresses the 
number of necrotic cell death. Thus, we have tried to use the fresh worms that were isolated very 
recently. Using these fresh chuck animals and comparing them with control animals which grow 
in the same condition as the tested strains helps us to prevent the variants between the 
experiments. Each bar corresponds to at least 30 or more than 90 animals (L3). In the necrotic 
neurogedegneration field standard error is used to show error bars. The Z test score was used to 
measure the statistical significant differences between strains and when there is statistical 
significant. It showed in the graph. We have tried to use excitotoxicity strain, which re-isolated 
from the new cross; thus, the similarities between the control and tested strain increase. The 
significant crosses were done twice in two different independent crosses and number of necrotic 
cell death was scored, to verify the effect of the stains. 
Fluorescence Microscopy Analysis: 
 
We used fluorescence microscopy to study the co-localization between GLR-1 and GRP-
1 (using Pglr-1::GLR‐1::RFP and grp-1(gm350) II; gmEx361 1 [Pgrp-1::gfp::grp-1]); and 
between GLR-1 and PPK-1 (using Pglr-1GLR‐1::RFP and Prab-3∷PPK-1∷GFP,lin-15(+)IV).  For 
that reason we did crosses and produce strains:GLR-1::RFP; gmEx361 1 [Pgrp-1::gfp::grp-1] and 
GLR-1::RFP; Prab-3∷ppk-1∷GFP lin-15(+).We placed the adult worms on 2% agar pad that 
contained sodium azide (that is able to paralyze worms in few second) and used an inverted 
microscope that has  Nomarski differential interference contrast (DIC) and epifluorescence optics 
to take different sets of pictures (red and green) of these worms. We used the GIMP program to 
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prepared and overlay these pictures for analysis. We used these technique to study the effect of 
LY294002 (the PI3K inhibitor) on AMPA receptor localization by comparing 
Pglr‐1GLR‐1::RFP with Pglr‐1GLR‐1::RFP +LY294002. 
Synchronizing the worm populations: 
 
To do behavior assays, worms were synchronized. Approximately 20 adult worms were 
placed in a plate that has OP50 and left there to lay eggs. After that the P0 worms were removed 
from the plate and the plate was placed in 20
0
C, so the eggs could hatch and worms could 
develop. 
Behavior Assays: 
 
Nose Touch: 
 
Nose touch sensitivity is controlled by glutamatergic activity of the avoidance circuit. L4-
adults synchronized worms were washed three times with M9 solution. Then an eyebrow hair 
attached to a toothpick was placed in front of the worms so that their nose would collide with the 
hair as they move forward. Nose touch sensation causes the worm to pause or retract. The 
number of worms that paused or went backward was counted and the fraction of responsive 
animals was calculated in each session. This experiment was repeated several times, so we would 
test 30 samples in each group.  
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Spontaneous Forward Mobility: 
 
The worm’s spontaneous mobility is typified by forward runs that are interrupted by short 
reversals, a process controlled by the forward and backward mobility circuits. The balance 
between forward and backward runs (or the duration of forward runs until they are interrupted by 
a reversal) is regulated by glutamatergic activity in these circuits. In this study, we used the 
Maricq lab protocol and determined the duration of forward movement of worms by measuring 
the time after which worms switched from forward to reverse movement 
131
.  
RNA interference (RNAi): 
 
This procedure is adopted from Dr. Savage-Dunn’s lab. The RNAi treatment was done by 
feeding. On the first day, a single clone of specific RNAi-expressing bacteria was picked up 
from the Ahringer library and was placed on Luria Broth medium (LB) agar plates that contain 
ampicillin and tetracycline. The plates were incubated overnight at 37
0
C. On the next day, a 
single bacterial colony was picked up and transferred to the 1ml of LB liquid culture which 
contains 50 μg/ml of ampicillin (LB+Amp) and incubated with shaking in 370C overnight. On 
the third day, the prepared bacterial over-night (stationary growth) culture was added to the fresh 
4ml of liquid LB+Amp and then was incubated in 37
0
C for four hours to grow the bacteria to 
logarithmic growth phase. After that, 450 µL of the bacteria culture was spread to the prepared 
RNAi plates that contained 400 mM IPTG (to induce RNAi production) and 50 μg/ml of 
ampicillin. On the fourth day, 4 -6 L4 worms were placed in these plates. On the fifth day these 
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worms were transferred to the new RNAi plates and after they lay eggs, the P0 animals were 
removed and the plate was placed in 20 
0
C, for further analyzes. 
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Results: 
1) Using RNAi to study the downstream targets of DAF-16: 
 
In our previous studies we demonstrated that the IIS cascade regulates neuroprotection in 
nematode excitotoxicity in correlation with nuclear localization (and hence activation) of 
FOXO/DAF-16. We are very interested to know what are the downstream transcriptional targets 
of DAF-16 that mediate this neuroprotection. Moreover, another PhD student in the lab (K. 
Genevieve Feldmann) has shown that another transcription factor, CREB/CRH-1, also provides 
neuroprotection in nematode excitotoxicity. Since these two transcription factors can cooperate 
on the activation of specific transcriptional programs 
132
, it is therefore possible/likely that 
critical neuroprotective genes are also co-regulated by CREB/CRH-1 and FOXO/DAF-16 when 
they exert their pro-survival effects. Previous studies by a number of groups in the worm aging 
field have pointed out a large number of genes regulated by DAF-16
133
 while other studies 
examined the genes targeted by CREB/CRH-1
134
. As an initial lead on possible neuroprotective 
genes, we compiled a list of 55 genes co-regulated by CREB & DAF-16. Although these genes 
were not identified in the same studies and their involvement in excitotoxicity has not been 
determined, they do provide a possible starting point in the search for co-regulated anti-
neurodegenerative genes. Testing such a number of genes by crossing their genetic KO strains 
with our excitotoxicity strain is highly labor intensive. As an alternative, we wanted to develop a 
system to test the effect of knock-down of these genes in nematode excitotoxicity by RNAi. 
Previously, it was shown that the C. elegans’ neurons are not sensitive to the RNAi, but certain 
mutations increase RNAi sensitivity in neurons. Therefore, we tried to generate a strain that 
would make our excitotoxicity strain more susceptible to RNAi. To that end, we crossed the 
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RNAi-sensitizing mutations rrf-3(pk1426) 
135
 or nre-1,lin15b
136
 with the excitotoxicity strain to 
make transgene  double mutants of (RNAi-sensitizing-mutation);glt-3;nuIs5. To assess the 
efficacy of this approach we tried to test if our new strain is sensitive to neuronal RNAi by 
monitoring the RNAi effect of a few genes that we previously showed by genetic mutation to be 
involved in excitotoxicity: crt-1, and glr-1 and glr-2. Due to difficulties constructing some of the 
other RNA—sensitizing strain combinations, I only have results on the use of rrf-3. 
 The genes that we used to test the efficiency of the RNAi effect were glr-1 & glr-2, 
which encode subunits of AMPA receptors. The second gene was crt-1, which is a gene 
encoding calreticulin, which is involved in the storage of Ca
2+
 inside the endoplasmic reticulum 
(ER). The experiment for the glr1-1;glr-2 on rrf-3;glt-3;nuIs5 was done only once. In that 
experiment we were not able to detect any significant changes in the level of neurodegeneration 
between the regular excitotoxicity strain treated with control RNAi and excitotoxicity animals 
treated with GluR RNAi (Figure 15a).  Although we saw some effects in early developmental 
stages, we  did not observe any changes in the number of dying cells when we inhibit the crt-1 in 
excitotoxicity strain in the most informative developmental stages (L3-L4, when most of the 
neurodegeneration takes place) (Figure 15b). We also note an overall lower level of 
neurodegeneration observed in these experiments: while in our pervious experiment, the level of 
neurodegeneration in L3-L4 in the excitotoxicity strain is between ~3.5-5 
111
 in our RNAi 
experiment the level of excitotoxicity in the control condition is between ~2-2.5. These effects 
may be result of many factors, either anecdotal (such as that the strain may not be fresh enough, 
making the mutation’s effect weaker), or substantive (such as that the mutation in rrf-3 reduces 
the overall level of neurodegeneration in the excitotoxicity strain). Therefore, we concluded that 
for confirmation these results, these experiments should be repeated. However, at this point 
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(given that crt-1 and GluR RNAi knockdown did not suppress excitotoxicity compared to 
control)  the current data suggests that including the rrf-3 in the excitotoxicity strain did not turn 
it into being RNAi sensitive. We are also trying to cross the excitotoxicity with nre-1;lin15b 
136
 
or neuronally expressed sid-1
137
 (other strains that make the worms’ neuron sensitive to RNAi).  
Screening the broad range of potential DAF-16 targets for their effect on excitotoxicity 
by RNAi therefore faces significant challenges, and at the moment is not feasible. In a related 
project conducted by a new PhD student in the lab, we are using another path to identify these 
specific neuroprotective genes by performing a Cell-type –Specific Transcriptome analysis 138. 
We hope that the more precise identification of neuroprotective genes in this approach (which is 
focused on genes that are co-regulated by CREB/CRH-1 under the specific conditions of 
excitotoxicity) will reduce the number and increase the informative quality of candidate genes, 
so that their effect can be studied by genetic KOs. 
a) 
 
n= 5-41 
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b) 
 
Figure 15 Determining the sensitivity of transgenic double mutants rrf-3;glt-3,nuIs5 to neuronal RNAi 
Figure 15: Determining the sensitivity of transgenic double mutants rrf-3;glt-3,nuIs5 to 
neuronal RNAi.  a,b) No significant changes were observed in number of dying neurons in L3 
when glr-1&glr-2; and crt-1 were knocked down in excitotoxicity strain.  
2) The Insulin/IGF Signaling (IIS) Pathway has a protective role in 
nematode excitotoxicity: 
 
Previously, we used an age-1 mutation or a drug called Pammaphysene A (PA) to activate / 
prevent the exit of DAF-16 from the nucleus. We were able to observe a reduction in number of 
excitotoxicity-induced necrotic cells, an effect also seen in both mouse neuronal cell cultures and 
also in C. elegans neurons 
124
. The observations that FOXO3/DAF-16 activation leads to cell 
survival is in contrast to reports from mammalian groups, who used other IIS-inhibiting 
pharmacological agents, who showed that inhibition of the IIS pathway increases cell death via 
apoptosis in both neurons and other cell types 
139
, raising the possibility that FOXO/DAF-16 
activation might have different effects on necrosis vs apoptosis.  Therefore, we have tried to 
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reconfirm the role of the IIS/Cell Stress Resistance Pathway in neuroprotection from excitotoxic 
necrosis. To study the effect, we did two manipulations: first we inhibited the IIS/ Cell Stress 
Resistance Pathway in the excitotoxicity strain glt-3;nuIs5 using the same pharmacological agent 
used in the mammalian studies, and secondly we  over-activated the IIS/ Cell Stress Resistance 
Pathway in the excitotoxicity strain glt-3;nuIs5 to test if we observe the opposite effect.  
 
2a) Pharmacological Inhibition of the insulin signaling pathway using 
LY294002 shows that inhibiting AGE-1 signaling is neuroprotective.  
 
  We inhibited the IIS pathway using LY294002, a widely used PI3K/AGE-1 inhibitor, in 
our excitotoxicity strain 
75,140
 . In addition to its wide use in mammalian studies, LY294002 was 
successfully used also in C. elegans aging studies 
75
, it is cell permeable and its action is 
reversible 
80
. We placed animals from the excitotoxicity strain on a plate that contains 0.2mM of 
LY294002 (in accordance of previously determined effective concentrations) and observed the 
level of neurodegeneration (daily transferring the worm to fresh LY295002 or control plates and 
observing neurodegeneration levels after 3 days in the presence of the drug or solvent). Placing 
the excitotoxicity strain animals onto plates that contain Ethanol, the solvent in which the drug 
dissolved, caused a small (but significant and reproducible) reduction in the level of 
neurodegeneration; however, there was an additional reduction in neurodegeneration in plates 
that also included the drug itself (Figure 16 a,b), showing that inhibition of the IIS pathway 
caused a significant reduction in number of dying neurons in the head of C. elegans compared to 
the sham-treated animal. Therefore, we were able to show that inhibition of the IIS with a widely 
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used anti- PI3K/AGE-3 drug reduces the extent of excitotoxic necrotic cell death (Figure 16 and 
Table1).  
a) 
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b) 
 
Figure 16 Inhibition of IIS using LY294002 
Figure 16: Inhibition of IIS using LY294002. Worm treated with LY294002 showed a 
significant reduction in the neurodegeneration in the head of L3 and L4 development stage 
compare to sham-treated worm. The experiment was done twice (months apart, with different 
stocks of the excitotoxicity strain). a is the first trial and b is the second trial. In all the bar graphs 
the standard Error showed by the bar and the *** represents p<0.01.  
2b) Wortmannin is not an effective drug in nematode excitotoxicity. 
 
Wortmannin is more potent than LY294002 when used in mammals, but unlike  
LY294002, there are no published reports of it being used in the C. elegans.
140
 In this 
experiment, we have used three different concentrations of Wortaminnin: 10µM, 100µM, and 
500µM, to determine its effect on the excitotoxicity (Fig 17 a,b,c and Table1).  First we tried 
10µM and we did the experiment twice (Figure 17a). Then we tried to treat the worms with the 
100µM of drug and we repeated this experiment three times (Figure 17b). In the last trial, we 
placed the worms in the 500 µM and we tried it only once (Figure 17c). Then, we counted the 
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number of necrotic cell deaths in the head of worms. Generally we did not observe any changes 
in the number of necrotic cells between the sham-treated worms and experimental worms.  
The only effect that we observed was in the L4 in 10 µM (figure 17a); however, we are 
not certain that we are observing the real effect because the results from the first trial was 
different from the second trial and changes did not also appear in higher concentrations of the 
drug. Based on these current results, we have no reproducible evidence to suggest that 
wortaminnin affects excitotoxicity. Wortamannin may not be effective as a result of few factors, 
such as a wrong concentration, inability of the drug to pass through the cuticle, rapid drug 
metabolism in the worm, or lack of affinity of this inhibitor to the nematode version of the PI3K 
enzyme.  Although we cannot determine the cause of lack of efficacy for wartmannin, the 
availability and effectiveness of the other PI3K inhibitor, LY294002, gives us a sufficient tool 
for our experiments. 
a)                                                                  b) 
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c) 
 
 
Figure 17 Inhibition of IIS using Wortmannin 
Figure 17: Inhibition of IIS using Wortmannin. The worms were treated with three different 
concentrations. a. Worms exposed to 10µM, some changes were observed in the level of cell 
death in L4 developmental stage.  b. Worms treated with 100µM of the drug. C. Worms were 
placed in Wortmannin 500 µM. In b and c no changes were detected in level of excitotoxicity. 
 
2c)  Over-activation of IIS/ Cell Stress Resistance Pathway by KO of zfp-1 
causes excessive degeneration. 
 
Zinc finger  protein 1 (ZFP-1) in C. elegans is a homolog of the mammalian protein 
AF10 
141
. ZFP-1 is a regulatory protein that under stress conditions inhibits the expression of 
pdk-1 
142
 protein in the IIS/Cell Stress Resistance pathway, allowing DAF-16 to translocate and 
stay in the nucleus. When DAF-16 goes to the nucleus, it promotes the transcription of ZFP-1, 
blocking pdk-1 transcriptional activation and causing a negative feedback on IIS pathway 
141
. 
This normally-operative negative feedback loop can be broken by zfp-1 KO, resulting in over-
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activity of the IIS cascade and under-activity of DAF-16. We crossed our excitotoxicity strain 
with zfp-1 (ok554).  We observed (Figure 18) that the zfp-1 mutation caused a significant 
increase in neurodegeneration under excitotoxic conditions, demonstrating that indeed over 
activity of the IIS cascade reduces the neuroprotective effect of DAF-16. These data complement 
our previous and current observations on mutations and treatments that increase DAF-16 nuclear 
localization increase neuroprotection. Therefore, contrary to mammalian data on FOXO3’s 
involvement in apoptotic cell death, we reaffirm that suppression of the IIS cascade and 
activation of FOXO/DAF-16 plays a role in neuroprotection from excitotoxic necrosis.  
 
Figure 18 Over-activation IIS increases neurodegeneration  in excitotoxicity strain 
Figure 18:  Over-activation IIS increases neurodegeneration  in excitotoxicity strain. A KO 
mutation in zfp-1 caused an increase in excitotoxic neurodegeneration.  ** represents p<0.05,   
 *** represents p<0.01. 
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3) The Cytohesin/GRP-1 Complex is involved in regulating excitotoxicity 
 
3a) Using a pharmocological approch to inhibit Cytohesin/GRP-1 
 
SecinH3 is an inhibitor of mammalian Cytohesin 1-3 and their fly homolog Steppke. 
SecinH3 binds to the  Sec-7 domain of cytohesins and prevents it from binding to ARF 
77,78,81
.  
Researchers working on insulin-induced metabolism have previously  shown that SecinH3 
affects the Insulin/IGF signaling pathway in flies and mammals, and prevents the exit of FOXO 
from nucleus 
77,78,81
.  We wondered if cytohesin is regulating IIS signaling in the context of 
nematode excitotoxicity. We therefore used SecinH3to see its effect on excitotoxicity.  
We placed the worms onto the plates that contained 50µM of SecinH3 for the 
experimental group, and 50µM of solvent for the control. Then we observed the level of 
excitotoxicity after two or three days. Treatment of worms with SecinH3 (which is supposed to 
inhibit GRP-1), showed no effect on the level of neurodegeneration (Fig 19 and Table1). We can 
not be sure if the lack of effect on excitotoxicity reflects a successful drug effect but no 
involvement of Cytohesin/GRP-1 in excitotoxicity, or an unsuccessful effect of the drug on the 
nematode protein. For example, it is possible that we used an inadequate concentration, since it 
was perviously shown that the drug’s IC50 for mammals and flies is different from the IC50 in 
yeasts 
78
. Alternatively, maybe the drug was not able to pass through the cuticle, making it 
ineffective. 
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Figure 19 Inhibition of Cytohesin/GRP-1 by SecinH3 
Figure 19. Inhibition of Cytohesin/GRP-1 by SecinH3. Worms were placed in the plate that 
contains 50 µM SecinH3 and the level of neurodegeneration was determined. There were no 
significant changes in the level of neurodegeneration. 
Table 1 
Treatment with drugs Dosages Number of necrotic cell deaths 
LY294002 (PI3K/AGE-1 Inhibitor) 0.2mM Reduced 
Wortmannin (PI3K/AGE-1 Inhibitor)   
10µM No effect 
100µM No effect 
500µM No effect 
SecinH3 (GRP-1 Inhibitor) 50µM No effect 
Treatment of excitotoxicity strain with different inhibitors 
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3b) Mutation of grp-1 reduces excitotoxic neurodegeneration. 
 
Since we were not able to get a clear result by pharmacological inhibition of 
Cytohesin/GRP-1, we decided to use a different approach, and study the effect of 
Cytohesin/GRP-1 in excitotoxicity using a genetic mutation. For that reason, we made a 
transgenic double mutants by crossing worms with a mutation in grp-1(tm1956) with the 
excitotoxicity strain glt-3;nuIs5.  We observed a significant reduction in neurodegeneration in L3 
and L4 stages (Figure 20 a,b and Table2). Therefore, we conclude that Cytohesin/GRP-1 plays 
an important role in excitotoxicity. We repeated the experiment in two completely independent 
isolates of this strain (obtained by separate crosses, months apart) and were able to replicate the 
results. 
a) 
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b) 
 
C) 
 
Figure 20 : Mutation in grp-1decreases the number of necrotic cells in excitotoxic conditions 
Figure 20: Mutation in grp-1decreases the number of necrotic cells in excitotoxic 
conditions. a) Number of dying neuronal cells was monitored and major reduction was observed 
in L3 and L4 when grp-1 is eliminated. b) The second trial with a new isolate of the strain and a 
fresh stock of control showed a similar effect. *** represents p<0.01  c) Images of nematode 
excitotoxic necrosis. On the right, an atypical example of an unusually high level of necrotic cell 
death occasionally seen in the glt-3;nuIs5. On the right: A typical level of necrotic cell death in 
the transgenic double mutants grp-1;glt-3;nuIs5. 
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3c)  Mutation of ARFs can affect neurodegeneration in the excitotoxicity strain.  
 
ARFs are also members of Cytohesin complex; they are small G-proteins that activate 
PIP5K/PPK-1, which in turn produces PIP2. Cytohesin/GRP-1 is a Guanine Exchange Factor 
(GEF) of ARF: Cytohesin/GRP-1 binds to ARFs through its sec-7 domain, causing it to bind 
GTP, stimulating ARF and resulting in PIP5K/PPK-1 activation and production of PIP2. PIP2 is 
a substrate for PI3K 
79
.Therefore, we wanted to study the involvement of ARFs in excitotoxicity. 
There are several subgroups of ARFs. Most of the mutations in ARFs in the C. elegans are lethal 
and can’t easily be tested in our system; therefore, we examined the effect of the arf-1.2 (ok796) 
ko mutation, which is not lethal. It was shown that ARF1.2 works the same pathway as 
Cytohesin/GRP-1 and its function overlap the ARF class III (ARF-6) 
127
. The transgene double 
mutants, arf-1.2;glt-3;nuIs5 exhibited a significant decrease in neurodegeneration in L3 animals, 
compared to glt-3;nuIs5 (Figure 21). These data further suggest that the Cytohesin complex is 
involved in excitotoxicity (Table2). 
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Figure 21 Mutation in arf1.2 decreases the number of necrotic cells in excitotoxicity strain 
Figure 21: Mutation in arf1.2 decreases the number of necrotic cells in excitotoxicity strain. 
arf-1.2 was crossed with glt-3;nuIs5.  The mutant Δarf-1.2;Δglt-3;nuIs5 showed a decreased in level of 
neurodegeneration in L3 *** represents p<0.01  .  
 
3d)  Over-expression of ppk-1 exacerbates neurodegeneration in the 
excitotoxicity strain  
PIP2 plays a critical role in different cellular processes, such as serving as a substrate for 
production of second messengers by Phospholipase C (PLC), serving as a membrane anchor for 
protein localization, regulation of actin in cytoskeleton, ion channel activity, vesicle trafficking, 
cell survival, and cell death. PIP2 is also a substrate for PI3K,  a member of the IIS pathway 
143
. 
PIP5K/PPK-1 is a member of the Cytohesin/GRP-1 complex that catalyzes the production of 
PIP2.  Thus, over-activation of PPK-1 increases production of PIP2, causing the over-activation 
of IIS. After finding that loss-of-function mutations in the Cytohesin complex reduce 
excitotoxicity, we wanted to see if its over-activation has the opposite effect. In our experiment, 
we used a strain that causes ppk-1 over-expression under pan-neuronal promoter (Prab-3::PPK-
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1) (previously shown to cause also over-activity of the enzyme 
130
) and crossed it with our 
excitotoxicity strain to determine its effect on neurodegeneration. We found a significant 
increase in neurodegeneration (Figure 22 and Table 2). Excitotoxicity begins to increase in L4, 
and increases even more in the adult; While this effect appears later in development than other 
effects we follow (which usually peak at L3) it correlates well  with previous studies, which 
showed that ppk-1 is mostly expressed in L4 and adult stages 
130
.  
 
 
Figure 22 Over expression of ppk-1 in the excitotoxicity strain 
Figure 22: Over-expression of ppk-1 in the excitotoxicity strain. Over expression of ppk-1 
increases of necrotic cell death in the excitotoxicity *** represents p<0.01. 
 
 
 
 
 
65 
 
 
Table 2 
Tested Genes Number of necrotic cells death 
zfp-1 (ok554) Increased 
grp-1(tm1956) Decreased 
arf-1.2 (ok796) Decreased 
Prab-3::PPK-1 (over-expression) Increased 
ced-4(n1162) No changes 
Crossing these genes with the Excitotoxcity strain and testing their effects on the excitotoxicity 
 
4) The Cytohesin/GRP-1 complex regulates the IIS pathway in nematode 
excitotoxicity. 
 
In the previous sections, I provided evidence to support that the components of the 
cytohesin complex regulate the extent of neurodegeneration in excitotoxicity. I would now like 
to demonstrate that the cytohesin complex exerts this neuroprotective effect by acting in the 
same pathway as the IIS cascade. I do this by performing an epistasis assay, to demonstrate that 
the effects of the Cytohesin complex and IIS are not additives, so that blocking this pathway in 
one stage gives the same neuroprotective effect as blocking the same pathway in two different 
stages of the cascade. To do this, I blocked the proposed cascade at the Cytohesin/GRP-1 level 
by a KO mutation, and at the AGE-1 level by using the inhibitory drug LY295002. We exposed 
grp-1;glt-3;nuIs5 worms to 0.2mM LY294002, and looked for additive effects on excitotoxicity 
(Figure 23a). We saw no changes in the level of neurodegeneration when comparing grp-1;glt-
3;nuIs5+ LY294002 (where the proposed pathway is interrupted twice) to controls (glt-3;nuIs5 
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+ LY294002 or  grp-1;glt-3;nuIs5 + solvent, where the proposed pathway is interrupted in one 
point or the other) (Figure 23b). Therefore, we conclude that Cytohesin/GRP-1 works in the 
same pathway as AGE-1 to regulate neuroprotection in nematode excitotoxicity.  
a) 
  
b) 
 
Figure 23 Epitasis study. 
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Figure 23: Epitasis study. to determine if Cytohesin/GRP-1 and AGE-1 work in the same 
pathway to affect the excitotoxicity.  a). A schematic of our proposed pathway, where the 
cytohesin complex is upstream of the IIS in regulating neuroprotection in excitotoxicity. b. There 
is no additive effect of age-1 and grp-1 on excitotoxicity *** represents p<0.01. 
 
5) Components of the Cytohesin/IIS cascade partially co-localize with 
components of the Glu signaling cascade 
 
Our longer-term goal is to address a model on which the signaling in the Cytohesin/IIS 
cascade is functionally associated with Glu signaling at the synaptic level. Previous mammalian 
studies have shown that GluRs can physically interact with PI3K
 60
 but the significance of such 
an association, whether it is mediated by the Cytohesin complex, and its effect on excitotoxicity 
remains unclear. As a first step in that direction, we wanted to check if such an interaction is 
possible by the physical presence of these two signaling cascades in the same cellular 
compartment by comparing the expression patterns of GLR-1 with that of PPK-1 and GRP-1. 
We used a strain of red-fluorescent–labeled GLR-1 that is correctly targeted to the postsynaptic 
density and is sensitive to receptor trafficking signaling dynamics 
144
. We crossed the GLR-
1::RFP: (odls16 [Pglr-1::GLR-1::rfp]) 
144
 with GRP-1::GFP: (grp-1(gm350) II; gmEx361 [Pgrp-1 
::gfp::grp-1]) 
127
 (Figure 24) and also crossed GLR-1::RFP: (odls16 [Pglr-1::GLR-1::rfp])
144
 with 
PPK-1::GFP: gqIs35 [Prab-3∷ppk-1∷GFP lin-15(+)]
130
 (Figure 25). Although these experiments 
do not show the direct association between glutamate receptors and the Cytohesin/GRP-1 
complex; they do however, suggest that PPK-1 and GRP-1 are both co-localized with GLR-1 in 
post synaptic neurons. 
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Figure 24 Partial Overlapping expression of the GLR-1 subunit of glutamate receptor and Cytohesin/GRP-1 
Figure 24: Partial Overlapping expression of the GLR-1 subunit of glutamate receptor and 
Cytohesin/GRP-1.  Anterior is left in all panels. The set of top panels shows a lateral view 
(dorsal is up), the bottom set of panels show a dorsal view of another animal.  Left panels: GLR-
1::RFP: (odIs16[Pglr-1::GLR-1::RFP]) . Middle panels: GRP-1::GFP: (grp-1(gm350) II; 
gmEx361 [Pgrp-1 ::gfp::grp-1])  . Right panels: Overlay of the images shows co-localization of 
the two labels. 
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Figure 25 Partial overlapping expression of GLR-1 and PPK-1 
Figure 25: Partial overlapping expression of GLR-1 and PPK-1. In all the pictures the 
anterior side is on the left. Up and bottom panels are dorsal pictures of two different worms. Left 
panels: GLR-1::RFP: (odls16 [Pglr-1::GLR-1::rfp);. Middle panels: PPK-1::GFP: Prab-3∷ppk-
1∷GFP lin-15(+) . Right panels: Overlay of the images shows co-localization of the two labels. 
 
6) Alternative explanations to the effect of Cytohesin/GRP-1 on 
excitotoxicity are not supported by our observations. 
 
Our observations suggest that the Cytohesin/GRP-1 complex regulates susceptibility to 
excitotoxic death so that its removal results in decreased death. We propose that this effect is 
mediated by the neuroprotective effect of IIS cascade interruption and the resulting increased 
protective effect of DAF-16. However, analysis of existing literature might suggest two 
alternative explanations to our data. a) Based on the studies of the Garriga group on the Q 
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neuroblast lineage, it is possible that Cytohesin/GRP-1 normally triggers apoptotic cell death, 
and the anti-apoptotic effect of its removal is neuroprotective. b) Based on mammalian studies of 
GluR surface expression it is possible that Cytohesin/GRP-1 & IIS directly control trafficking of 
GluRs, so that modulating the activity of the IIS signaling changes the balance of GluR 
trafficking, reduces the level of functional GluRs at the synapse, and reduces excitotoxicity. In 
this section, I present experiments that address these two possible alternative explanations of 
Cytohesin/GRP-1’s effect. 
6a) Canonical apoptosis, which could be modified by Cytohesin/GRP-1, 
does not have a detectable role in nematode excitotoxicity.  
 A few studies show that Cytohesin/GRP-1 plays a role in apoptosis following asymmetric cell 
divisions of post-embryonic neuroblasts, where the KO of grp-1 causes the inappropriate 
survival of  some of the neuroblast  sister cells 
127,128
. If apoptosis is part of the process of cell 
death in nematode excitotoxicity, an anti-apoptotic effect of grp-1 KO will suppress 
neurodegeneration. To address the role of canonical apoptosis in nematode excitotoxicity, one of 
our lab members (John Del Rosario) crossed the ced-4(n1162) mutation with the excitotoxicity 
strain to create combination mutants ced-4;glt-3;nuIs5 (Figure 26). We assumed that if apoptosis 
is involved as an alternative route for neurodegeneration, then by inhibiting apoptosis we would 
have more cell death with necrosis. In contrast, if canonical apoptotic mechanisms mediate some 
of the steps in what we see as excitotoxic necrosis, then blocking canonical apoptosis will reduce 
the appearance of necrotic corpses. However, there was no significant difference in the level of 
neurodegeneration, regardless of the presence or absence of the canonical apoptosis mediator 
ced-4. Therefore, we concluded that apoptosis does not play a role in nematode excitotoxicity 
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(Figure 26, Table 2), and the effect of grp-1 KO cannot, therefore, be attributed to its potential 
effect on apoptosis.  
 
Figure 26 Data by John Del Rosario: Apoptosis does not play a role in nematode excitotoxicity 
Figure 26: Data by John Del Rosario: Apoptosis does not play a role in nematode 
excitotoxicity.  The level of neurodeneration was measured in Δced-4; Δglt-3;nuIs5; however, 
there is no significant changes in level of excitotoxicity. 
6b) The Cytohesin/GRP-1 complex and IIS pathway do not grossly modify 
the balance of expression and internalization of AMPA Receptors to 
decrease the level of neurodegeneration:  
Several mammalian studies showed that insulin and PI3K regulate trafficking of AMPA 
receptors in LTD and LTP 
58,60
. Thus, there may be an alternative explanation to the 
neuroprotective effect of grp-1 ko on nematode excitotoxicity claiming that inhibition of IIS 
causes changes in AMPA receptor trafficking, and ultimately reduced neurodegeneration. To 
provide a preliminary visual test of this theory, we treated the worms GLR-1::RFP: 
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(odIs16[GLR-1::RFP]) with 0.2mM of LY294002 (the same drug used in some of the 
experiments with mammalian AMPA-R trafficking) and then we studied the AMPAR expression 
in the nerve ring. We were not able to observe gross visual changes in AMPA receptor 
fluorescence labeling in the nerve ring when comparing between drug treated worms and sham-
treated worms (Figure 27a). AMPA-R functional synaptic expression level (which is affected by 
receptor trafficking) can also be tested using a more sensitive behavior assay 
131,145,146
. 
Behaviors such as nose touch sensitivity and the duration of spontaneous forward runs (or 
frequency of reversals) are mediated by glutamatergic circuits that are highly sensitive to the 
functional strength of the synapses. Therefore even small changes in GluR trafficking have 
strong effects on these behaviors. 
Such behavioral studies were recently performed by a new lab member who is now 
continuing my project, Ayesha Chowdhury. Ayesha conducted two nose touch behavior assays; 
in the first assays, she compared the grp-1 with the control (Figure 27b) and in the second assay, 
she studied the effects of mutation of age-1 and Tamalin/gras-1 and compared them with the 
control (Figure 27c). However, Ayesha was not able to observe any significant changes in the 
worms’ behavior. Ayesha also did a forward mobility assay and in that experiment she compared 
the age-1 mutants and Tamalin/gras-1 KO with controls; nevertheless, there were no major 
differences in mobility between age-1 or gras-1 mutant animals and WT, suggesting that these 
mutations do not modify the level of activity of glutamatergic synapses (Figure 27 d).   
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a) 
 
b) 
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c) 
 
d) 
 
 
Figure 27 Determination of the effect of IIS and Cytohesin complex members on behaviors that are sensitive to the strength 
of synaptic glutamatergic signaling (usually modified by regulating GluR trafficking 
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Figure 27. Determination of the effect of IIS and Cytohesin complex members on behaviors 
that are sensitive to the strength of synaptic glutamatergic signaling (usually modified by 
regulating GluR trafficking). a) The inhibition of IIS (using LY294002) did not affect GLR-1 
expression (the image shows two different animals for each of the two condition, upper panels in 
lateral view, lower panels in dorsal view). b,c). Two nose touch assays were conducted to study 
the effect of IIS on GluRs; however, no significant differences were detected. d) The forward 
mobility behavior assay did not show any signification differences in the duration of spontaneous 
forward mobility. 
 
7)  A preliminary assessment of the effect of a mutation in grp-1 on the 
nuclear translocation DAF-16 faced technical difficulties.  
 The observations described above, contradicting other alternative explanations for our 
observations, therefore lend further support for our model for the involvement of 
Cytohesin/GRP-1 in nematode excitotoxicity. These observations therefore support that 
Cytohesin/GRP-1 stimulates the IIS cascade to prevent activation of FOXO/DAF-16 by its 
nuclear translocation. In a previous study we have demonstrated that indeed a drug-mediated 
body-wide nuclear translocation of DAF-16 correlates with neuroprotection from excitotoxicity 
124
. We now want to test if this correlation can be seen also with the grp-1 mutation and 
specifically in the dying neurons. Two previous studies, using Drosophila and mammalian liver 
cell cultures, showed that the mutation or inhibition of Cytohesin causes FOXO to translocate to  
the nucleus 
77,78
. We wanted to extend these studies to the effect of grp-1 in nematode 
excitotoxicity. Therefore, we decided to combine a grp-1 ko, a DAF-16 sub-cellular reporter 
(labeled with mCherry) expressed from a native daf-16 neuronal promoter (gifted from Dr. 
Ruvkun’s lab), and a GFP marker of the postsynaptic glr-1 expressing neurons. We crossed 
pCR264 [daf-16-p::daf-16b::LAP(Spep-TEV-mCherry)::daf-16-3’UTR::Cb_unc-119]III with  
Pglr-1::GFP to produce Pdaf-16b::mCherry::unc119;Pglr-1::GFP  to observe the effect on DAF-16 
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localization. However, the background mCherry of this particular DAF-16 reporter strain was 
very strong, labeling many cells, and exhibiting “clumpy” subcellular distribution, making it 
very hard to separate between two individuals cells and detect cytoplasmic vs nuclear expression 
(Figure 27). These results are therefore inconclusive, and we decided later on to use another 
strain (with a better cytoplasmic vs nuclear expression labeling in neurons 
147
, using GFP 
labeled DAF-16 and DsRed label in glr-1 expressing neurons) to determine if grp-1 ko has an 
effect on DAF-16 translocation in postsynaptic neurons. 
 
 
Figure 28 : Potential effect of grp-1 KO on DAF-16 nuclear vs cytoplasmic localization 
Figure 28: Potential effect of grp-1 KO on DAF-16 nuclear vs cytoplasmic localization.  
DAF-16 and Pglr-1 expression in WT (upper panels) and grp-1 KO (lower panels) worms (in both 
sets of images, the anterior sides of worms is left and dorsal is up).  In each set, panels on the left 
shows postsynaptic neurons expressing glr-1 (using a transcriptional reporter  Pglr-1::GFP; the 
panels in the middle show DAF-16 expression (using a full length translational reporter and the 
neuronal daf-16b variatio pCR264[daf-16-p::daf-16b::LAP(Spep-TEV-mCherry)::daf-16-
3’UTR::Cb_unc-119]III) . The right panels show the overlay of these two markers.  In the upper 
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set these reporters are expressed in WT background, in bottom set we express them in the grp-1 
(tm1956) background.  The complexity of the DAF-16 signal prevents clear identification of 
nuclear vs cytoplasmic labeling in glr-1 expressing neurons. 
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Conclusions: 
In this thesis I study the effect of the IIS cascade and its upstream regulators (assembled 
into the cytohesin complex) on necrotic neurodegeneration in a C. elegans model of 
excitotoxicity. Previously it was shown that excitotoxicity plays a significant role in many 
diseases, such as Alzheimer’s, ALS, Huntington’s disease and stroke. Research in mammals 
showed that the IIS pathway has several  functions in the body:  metabolism, aging, 
developmental, and cell arrest 
139
. Mammalian studies also showed that activation of AKT (a 
member of the IIS pathway) increases neuroprotection 
148
 and  FOXO is involved in the 
activation of  apoptosis  by activating the expression of a pro-apoptotic protein called bim 
149
.  
On the other hand, C. elegans studies showed that inhibition of IIS pathway and activation of 
FOXO/DAF-16 reduces cell stress and increases cell survival and neuroprotection in a number of 
scenarios 
150
. Even though we were previously able to demonstrate that inhibition of IIS reduces 
the neurodegeneration in the C. elegans excitotoxic necrosis model
124
, because of the superficial 
contradiction with mammalian apoptotic neurodegeneration studies we decided to reaffirm  these 
results. Indeed, we were able to show that inhibition of IIS pathway using the same drug used in 
the mammalian apoptotic neurodegeneration studies (LY294002) reduced neurodegeneration in 
the C. elegans excitotoxic necrosis model. Furthermore, over-activation of IIS pathway (using 
zfp-1 ko) increases the level of neurodegeneration. These two experiments reaffirm the 
involvement of IIS pathway in necrotic neurodegeneration in the excitotoxicity model.   These 
observations suggest that although FOXO/DAF-16 might have a pro-death effect in apoptotic 
neurodegeneration, it has a neuroprotective effect in excitotoxic necrosis. Since excitotoxic 
necrosis is the main mode of neurodegeneration at the core of the stroke area, activation of 
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FOXO/DAF-16 –triggered neuroprotective programs might offer a new approach to addressing 
critical excitotoxic damage. 
We next tried to look at upstream regulators of the IIS cascade. Since it is potentially 
linked to Glu signaling, we focused our study on the effect of a Cytohesin/GRP-1 complex 
77,78
. 
We first studied the effects of inhibition of the Cytohesin/GRP-1 complex; thus, we crossed the 
grp-1 KO and arf-1.2 KO with our excitotoxicity strain and determined the level of excitotoxicity 
in these strains. We were able to observe significant reduction in the level of neurodegeneration 
in the L3 developmental stage.  We then studied the opposite effect, where the Cytohesin 
complex is hyperactive. To this end we crossed the over-expression strain of ppk-1 with our 
excitotoxicity strain. Indeed, we saw that ppk-1 overexpression increased the level of 
neurodegeneration. However, instead of observing changes in L3, we observed increases in the 
level of neurodegeneration in the developmental stage L4 and adult. This result is comparable 
with a pervious study that showed that the changes in ppk-1 mutants begin in L4 and adult  and 
that is result of expression of  ppk-1 in the L4 and adult developmental stages 
130
.  
To demonstrate that the Cytohesin/GRP-1 works in the same pathway as IIS pathway we 
did an epistasis test. We were able to show that the Cytohesin/GRP-1 complex works in the same 
pathway as the IIS pathway to affect the neurodegeneration.   
Studies from other researchers suggest that there may alternative explanations for 
observing these results. For example, there is evidence that the Cytohesin/GRP-1 plays a role in 
apoptosis and PI3K has effects on trafficking of AMPA receptors. However, we were able to 
show that these factors do not play effective role in an excitotoxicity model.  
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Since our long term goal is to be able to determine the connection between glutamate and 
the Cytohesin/GRP-1 complex and their effects on neurodegeneration, we tried to observe if 
there is physical co-localization of GRP-1 or PPK-1 with the glutamate receptor subunit GLR-1. 
We were able to make two strains: in one of them GRP-1::GFP expressed with GLR-1::RFP, and 
in the other one  PPK-1::GFP is expressed with GLR-1::RFP. We were roughly able to show 
some co-localizations between GRP-1::GFP and GLR-1::RFP and PPK-1::GFP and GLR-
1::RFP. These results are preliminary. Further analysis of such colocalization requires better 
image analysis. Moreover, the concept of GluR-IIS cross-complexing and functional cross-talk 
can be further established using co-immunoprecipitation (co-IP) and disruption of potential 
complex by overexpression of partial protein fragments. 
In conclusion, based on our studies, we propose that Cytohesin/GRP-1 complex affects 
excitotoxicity through the IIS Pathway, by activating the IIS and preventing FOXO/DAF-16 
from entering into the nucleus and activating the genes involved in neuroprotection. In the future 
we hope that we would be able to recognize a cross talk between glutamate signaling and the IIS 
cascade through a scaffold protein that connects the glutamate ionotropic receptor to the 
Cytohesin/GRP-1 complex. We also hope to identify the genes that are activated by 
FOXO/DAF-16 and are involved in neuroprotection, with special emphasis on genes activated 
by both CREB and FOXO (Figure 29)  
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Figure 29 : Schematic picture for a model for regulation of susciptability to excitotoxicity by the Cytohesin complex 
Figure 29: Schematic picture for a model for regulation of susciptability to excitotoxicity by 
the Cytohesin complex. In this model we show how Cytohesin/GRP-1 complex and IIS are 
regulating the transcriptional program activated by FOXO/DAF-16 to provide neuroprotection 
from excitotoxicity. 
Our data provides novel insights to the mechanism that regulates susceptibility to 
excitotoxic neurodegeneration and suggest that the Cytohesin complex is an important regulator 
of IIS-mediated neuroprotection. We hope to continue investigating this process and provide new 
directions in the study of excitotoxic necrosis in both nematodes and mammals, which might 
eventually lead to novel avenues of intervention in brain ischemia and stroke. 
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